|
|
Opinion
Topic has 115 replies.
  
|
|
Sort Posts:
|
|
|
|
 13/05/2009, 8:29 PM
|
Hide the decline
Joined on 12/03/2008
Posts 1,356
|
|
|
|
|
|
|
28/05/2009, 8:39 PM
|
Hide the decline
Joined on 12/03/2008
Posts 1,356
|
|
|
 ironsmad wrote: | | GreenBlue wrote: | | ironsmad wrote: | |
NWO explanation is rubbish!
Two American Presidents, Franklyn Roosevelt and Woodrow Wilson, and a British Prime Minister, David Lloyd George, and the Emperor of Ethiopia, Haile Selassie, are all known to have been infected by the Spanish Flu and to have recovered from it.
"There were some odd facts about the Spanish Flu epidemic. It came apparently out of nowhere, and even now no-one has any idea exactly where it arose, or how the strain mutated to infect humans"
http://hubpages.com/hub/Spanish-Flu-historical-event-or-precursor-of-H5N1-Bird-Flu |
|
, but when US researchers create nasty germs "so we can explore what bioterrorists might do", you can see why they get suspicious.
Once
the US gets hold of Indonesia's virus, Supari concludes, "it is a
matter of choice whether to use the material for vaccines or biological
weapon development." The choice "depends on the need and interest of
the US Government"
Editorial: Self defence over bird flu is no crime - health - 17 February 2007 - New Scientist
A nasty little virus that could be used on the tali-band and others, just spread it around on some other folk.To make it look like a flu pandemic
|
|
advanced forms of biological warfare
that can “target” specific genotypes may
transform biological warfare from the realm
of terror to a politically useful tool.
http://www.aztlan.net/RebuildingAmericasDefenses.pdf
Mexicans are now endangered by
ethnic specific bio-weapons
by
Ernesto Cienfuegos
La Voz de Aztlan
 |
| President Felipe Calderon unveils Mexican genome map on May11, 2009 in Mexico City.
|
 |
| Former Mexican
Minister of Health Julio Frenk now at Harvard. He is the principal
architect of the project that mapped Mexican genes, |
Los Angeles, Alta California - May 20, 2009 - (ACN) Mexican President
Felipe Calderon may have made a grave mistake in allowing the creation
and foreign funding of the "Instituto Nacional Mexicano de Medicina
Genetica" (INMEGEN) which recently completed the mapping of genetic
markers in Mestizos and Indigenous ethnic groups in Mexico. The Mexican
genetic map project was undertaken with minimum publicity and very
little public input. The project took four years to complete and cost
approximately 25 million dollars.
The project results were just announced on May 11 mostly through the
former Minister of Health of Mexico Julio Frenk who is now
collaborating with Harvard University in Massachusetts. Julio Frenk is
a Mexican Jew with ties to Neocons at Harvard University. He was a
controversial Minister of Health under President
Vicente Fox and was criticized by the Catholic Church for his policies
of reducing Mexico's population. Frenk was accused by the Archbishop of
Mexico City Norberto Rivera Carrera of the mass distribution of the
morning after pill to Indigenous women through government health
clinics. Presidents Calderon and Fox are both members of the Partido
Accion Nacional (PAN) which is a lot like the Republican Party in the
USA.
Harvard University is one of many centers for research
concerning ethnic or race specific biological weapons. These weapons
target and kill only people with certain genetic markers such as those
that the Mexican genome project
identified in Mestizos and Indigenous groups (ie. Mexicas, Zapotecas
etc.). In fact, the Harvard Neocon Steve Rosen is a significant
participant in these efforts. Rosen is a Professor of National Security
and Military Affairs at Harvard and is one of the authors of "Rebuilding America's Defenses: Project for a New American Century"
which on page 60 says "... the art of warfare ... will be vastly
different than it is today ... 'combat' likely will take place in new
dimensions ... advanced forms of biological warfare that can 'target'
specific genotypes may transform biological warfare from the realm of
terror to a politically useful tool." Other contributors to "Rebuilding
America's Defenses" were Neocons (Zionists) Paul Wolfowitz, Alvin
Bernstein, Eliot Cohen,
David Epstein, Abram Shulsky, Dov Zakheim, Aaron Friedberg and others.
 |
| Nurses taking the blood of Indigenous women in Oaxaca to identify their genetic markers.
|
 |
| Zapotec woman's blood is drawn to determine genetic markers.
|
Microbiologists
have been warning about ethnic specific bio-weapons for many years now.
In 1998 Dr Vivienne Nathanson, Chief of Health Policy Research of
the British Medical Association, warned that certain countries had
active research programs into ethnic specific biological weapons. That
same year the London Times published a report that Israel was
developing an ethnic specific bio-weapon to target Arabs(Palestinians)
at its secret Institute for Biological Research (IIBR) located in Ness
Ziona which is about 20 kilometers south of Tel Aviv. A scientist
quoted in the report said, "They have succeeded in pinpointing a
particular characteristic in the genetic profile of certain Arab
communities, particularly the Iraqi people." The report was later
affirmed by
David Dedi Zucker, a member of the Knesset (Israeli parliament).
In addition, in 2007 the Islamic Republic of Iran reported that the
USA, in cahoots with Israel, was in the process of producing and
testing ethnic specific bio-weapons. At an international conference,
Iranian General Mir Feysal Bagherzadeh said that the US, in
collaboration with the Zionist regime of Israel,were preparing for
sinister biological warfare. General Bagherzadeh said, "... they are
seeking to manufacture a weapon which could kill specific peoples in a
limited geographical area." The General further pointed out that the
move should be considered as a case of genocide, "because they intend
to massacre specific peoples and ethnicities" with the help of this
weapon. He said a number of US experts were conducting activities and
research in Bosnia and Herzegovina in the same line. General
Bagherzadeh also said, "... during a crash of a Thai plane, the US and
Israeli experts were looking for the corpses of Iranian nationals in a
bid to provide for their needed genes." "The US and Israel are seeking
to manufacture a new generation of weapons in an effort to immunize
themselves and annihilate other nations and peoples," he added.
 |
| Mexican biologists probably duped and unwittingly participating in the genome project.
|
 |
| Mexicans answer questions concerning family background prior to having their blood drawn.
|
Today
there are indications that the Swine Flu virus, A(H1N1), which has
devastated Mexico was engineered in a laboratory. The virus is very
similar to the Spanish Flu virus that killed millions in 1918. The
Spanish Flu virus is also a type A(H1N1) with a few genetic
differences. The 1918 Swine Flu virus genome has been sequenced by
virologist Jeffery Taubenberger of the US Armed Forces Institute of
Pathology (AFIP) which makes it possible to now create a variety of
A(H1N1) viruses with different characteristics.
It may be that the Neocons have now implemented their goal outlined in
their manifesto "Rebuilding America's Defenses." That goal was stated
very clearly on page 60 of the document and that was to implement "...
advanced forms of biological warfare that can 'target' specific
genotypes..." Why have Mexicans been the only ones to die in large
numbers in the current Swine Flu pandemic? The graphic below shows very
clearly that even though the Swine Flu has now spread widely in North
America, it has been primarily Mexicans that have died from the
infection. Out of 117 deaths reported on May 6, 115 have been Mexicans.
The other 2 were non-Mexicans whose health was already compromised.
Has the Pentagon and the Neocons implemented a test of an
ethnic specific bio-weapon in Mexico with the unwitting cooperation of
the Mexican government through the recently completed genome mapping of
Mexicans and the Harvard University connection? Only time will tell.
One thing for sure though, we must be more vigilant than ever if we are
to survive as a people. Also, a sincere warning for all other peoples
of the world; it may be us today but tomorrow it may be you!
|
|
|
|
|
Report
|
|
|
|
|
02/06/2009, 9:29 PM
|
Hide the decline
Joined on 12/03/2008
Posts 1,356
|
|
|
|
| ironsmad wrote: | | GreenBlue wrote: | | ironsmad wrote: | Try reading what Dr John said Bluebottle
It is very early days at the moment, so it is important to avoid speculation. What we know about this particular strain is it does seem to be spreading rapidly, but outside Mexico cases the cases have been relatively mild and I'm not aware of any deaths.
“So if that continues, then I guess we can anticipate it will spread to the UK at some stage and we will get people infected with a similar, relatively mild illness.
“But in the last few days it has become clear things can change and that is one of the first elements of uncertainty that goes with a potential pandemic.”
No safe vaccine exists for swine flu, and Dr Battersby believes one is at least three or four months away.
Paul Hunter was more on the ball
Paul Hunter, professor of health protection at the University of East Anglia, said he was concerned just how many cases had been reported in other countries since the Mexican outbreak.
He said: “Although it is always very difficult to predict the course of an outbreak this early on, the fact that cases are already being reported from around the world is of concern. This suggests to me that the virus certainly does have epidemic potential.”
http://www.cdc.gov/swineflu/masks.htm?s_cid=tw_epr_76
The outbreak of disease in people caused by a new influenza virus of swine origin continues to grow in the United States and internationally. Today, CDC reports additional confirmed human infections, hospitalizations and the nation’s first fatality from this outbreak. The more recent illnesses and the reported death suggest that a pattern of more severe illness associated with this virus may be emerging in the U.S. Most people will not have immunity to this new virus and, as it continues to spread, more cases, more hospitalizations and more deaths are expected in the coming days and weeks.
 Protection: Karya Lustig, a trainer at California’s La Clinica de la Raza, shows clerks how to use protective respiratory masks
Masks are going like hotcakes in Britain, the head bags tend to get steamed up.
|
|
Try rereading Doc Battersby "so it is important to avoid speculation"
That's what you are doing mad, and scaremongering spectulation at that. |
|
http://video.google.co.uk/videoplay?docid=-8674401787208020885
|
|
 | | Boxes
of Tamiflu |
01 June 2009 10:30
Try rereading Doc Battersby "so it is important to avoid speculation"
That's what you are doing mad, and scaremongering spectulation at that. Who's scaremongering now, a not so secret location if you enlarge the pic on the labels. its just off the **** road.
Norfolk’s population was 840,700 in mid-2007, an increase of around
8,200 from mid-2006, as against an increase of 6,500 over the
previous twelve months;
Not enough anti-viral for the population for Norfolk,come the flu season.
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
MedImmune, the global biologics unit of AstraZeneca, announced today
that it has submitted a Marketing Authorisation Application (MAA) for
its nasal spray live attenuated influenza vaccine (LAIV), which is now
being reviewed by the European Medicines Agency (EMEA). The proposed
indication in the MAA is for prevention of seasonal influen
MedImmune | Press Room | Press Room Overview
GAITHERSBURG, Md., June 1 /PRNewswire/ -- MedImmune announced today that
the U.S. Department of Health and Human Services (HHS) has awarded the company
a contract to manufacture monovalent (single-strain) live attenuated influenza
vaccine for Novel Influenza A (H1N1) to vaccinate priority populations
identified by HHS in the National Strategy for Pandemic Influenza. An initial
order of $90 million of vaccine has been placed, with the potential for
additional orders.As a needle-free nasal spray, LAIV is well suited to facilitate mass
vaccination .
LAIV is different from the injectable influenza vaccine ("flu shot") in that
it is a gentle mist sprayed into the nose, where the influenza virus usually
enters the body. It contains live vaccine virus strains that are weakened so
as not to cause the flu
Boxes of the antiviral drug Tamiflu pack a Norfolk warehouse almost to the ceiling, ready for an outbreak of swine flu.
The
warehouse, in a secret location in the county, contains 95,000 boxes of
the drug, each enough for one person. They completely filled a 40-tonne
articulated lorry when they arrived.
If there is an outbreak and
more is needed, Norfolk can receive up to twice that amount again
within days from a national distribution centre.
And health
chiefs are ready to open a collection point for the drugs within 24
hours of the outbreak, with three more to follow within 48 hours, and
up to 30 more across the county if needed.
But health chiefs are warning that residents must not become complacent and should be prepared for when the disease does strike.
There
has still not been an outbreak of swine flu in Norfolk, although there
has been one case in Lowestoft. But the risk of new cases is higher
this week as people have just returned from half-term holidays to
affected countries, particularly Mexico and the United States.
Leading
public school Eton is closed this week because of an outbreak, and the
Health Protection Agency says there has been “widespread transmission”
between pupils at the school.
So far the disease has been
similar to normal seasonal flu in severity. But because the elderly
have been relatively little affected, the 229 confirmed cases in
Britain so far have not caused many complications.
John
Battersby, NHS Norfolk's director of public health, said: “There will
come a time when we see cases within Norfolk. Our health teams are
prepared, and we are working closely and effectively with other
agencies, but we need the public to keep themselves aware and to make
their own preparations.
“One of the biggest problems we could
face is people becoming complacent about swine flu, and thinking that
none of these messages relate to them. They relate to all of us. This
is not about panic, it's about sensible preparation.”
Most of
the cases so far have been in the under-50s, with ages 15-20 the most
affected. Few elderly people have caught the disease. Dr Battersby said
they would have some immunity developed from being exposed to similar
strains in the
past.
He said the Health Protection
Agency's modelling suggested the disease would “burn for a long time”
with a steady flow of cases, rather than a surge or the disease
disappearing altogether.
Taking the Tamiflu delivery posed
unusual logistical problems. Dr Battersby said: “We were asking for
information about sheer volume and didn't get particularly accurate
information. Then it arrived and it was a 40-tonne articulated lorry
crammed full. The logistics of moving it around were quite
considerable.
“It comes on pallets. A lot of pharmacy doorways
aren't designed to take stock on pallets, so it has to be unloaded to
get it off.”
If there is an outbreak, the drugs will be
collected by “flu friends” of those affected, rather than by the ill
person, to avoid spreading it. The first collection centre to open in
the county is planned for Norwich and the first in Yarmouth and Waveney
is due to be Lowestoft, but health trusts are trying to keep it
flexible so they can react to the outbreak as it happens.
Alistair
Lipp, director of public health at NHS Yarmouth and Waveney, said: “We
are developing plans to respond to increasing numbers of swine flu
cases. We hope that won't happen.
“We have stocks of face
masks and stocks of antivirals and plans to distribute them. We are
training staff to run the centres. GPs are working together and as they
get busier they will support each other, and we will support the
out-of-hours service too.”
A vaccine is being developed and
there are likely to be two immunisation programmes this winter - one
for seasonal flu as usual and one for swine flu - which may be targeted
at different groups.
People are being asked to choose a “flu
friend” who can help if they become ill, and to remember the importance
of good hygiene in stopping the disease.
Anyone concerned that
they may be displaying swine flu symptoms or have recently come into
close contact with someone who has, is advised to stay at home and
contact their GP by phone or seek advice from NHS Direct on 0845 4647.
|
|
|
|
|
Report
|
|
|
|
|
02/06/2009, 10:59 PM
|
GreenBlue
 
Joined on 01/06/2008
Posts 1,598
|
|
|
|
| ironsmad wrote: | | ironsmad wrote: | | GreenBlue wrote: |
| ironsmad wrote: | Try reading what Dr John said Bluebottle
It is very early days at the moment, so it is important to avoid speculation. What we know about this particular strain is it does seem to be spreading rapidly, but outside Mexico cases the cases have been relatively mild and I'm not aware of any deaths.
“So if that continues, then I guess we can anticipate it will spread to the UK at some stage and we will get people infected with a similar, relatively mild illness.
“But in the last few days it has become clear things can change and that is one of the first elements of uncertainty that goes with a potential pandemic.”
No safe vaccine exists for swine flu, and Dr Battersby believes one is at least three or four months away.
Paul Hunter was more on the ball
Paul Hunter, professor of health protection at the University of East Anglia, said he was concerned just how many cases had been reported in other countries since the Mexican outbreak.
He said: “Although it is always very difficult to predict the course of an outbreak this early on, the fact that cases are already being reported from around the world is of concern. This suggests to me that the virus certainly does have epidemic potential.”
http://www.cdc.gov/swineflu/masks.htm?s_cid=tw_epr_76
The outbreak of disease in people caused by a new influenza virus of swine origin continues to grow in the United States and internationally. Today, CDC reports additional confirmed human infections, hospitalizations and the nation’s first fatality from this outbreak. The more recent illnesses and the reported death suggest that a pattern of more severe illness associated with this virus may be emerging in the U.S. Most people will not have immunity to this new virus and, as it continues to spread, more cases, more hospitalizations and more deaths are expected in the coming days and weeks.
Protection: Karya Lustig, a trainer at California’s La Clinica de la Raza, shows clerks how to use protective respiratory masks
Masks are going like hotcakes in Britain, the head bags tend to get steamed up.
|
|
Try rereading Doc Battersby "so it is important to avoid speculation"
That's what you are doing mad, and scaremongering spectulation at that. |
|
http://video.google.co.uk/videoplay?docid=-8674401787208020885
|
|
 |
| Boxes of Tamiflu |
01 June 2009 10:30
Try rereading Doc Battersby "so it is important to avoid speculation"
That's what you are doing mad, and scaremongering spectulation at that.
Who's scaremongering now, a not so secret location if you enlarge the pic on the labels. its just off the **** road.
Norfolk’s population was 840,700 in mid-2007, an increase of around
8,200 from mid-2006, as against an increase of 6,500 over the
previous twelve months;
Not enough anti-viral for the population for Norfolk,come the flu season.
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
MedImmune, the global biologics unit of AstraZeneca, announced today that it has submitted a Marketing Authorisation Application (MAA) for its nasal spray live attenuated influenza vaccine (LAIV), which is now being reviewed by the European Medicines Agency (EMEA). The proposed indication in the MAA is for prevention of seasonal influen
MedImmune | Press Room | Press Room Overview
GAITHERSBURG, Md., June 1 /PRNewswire/ -- MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has awarded the company a contract to manufacture monovalent (single-strain) live attenuated influenza vaccine for Novel Influenza A (H1N1) to vaccinate priority populations identified by HHS in the National Strategy for Pandemic Influenza. An initial order of $90 million of vaccine has been placed, with the potential for additional orders.As a needle-free nasal spray, LAIV is well suited to facilitate mass vaccination . LAIV is different from the injectable influenza vaccine ("flu shot") in that it is a gentle mist sprayed into the nose, where the influenza virus usually enters the body. It contains live vaccine virus strains that are weakened so as not to cause the flu
Boxes of the antiviral drug Tamiflu pack a Norfolk warehouse almost to the ceiling, ready for an outbreak of swine flu.
The warehouse, in a secret location in the county, contains 95,000 boxes of the drug, each enough for one person. They completely filled a 40-tonne articulated lorry when they arrived.
If there is an outbreak and more is needed, Norfolk can receive up to twice that amount again within days from a national distribution centre.
And health chiefs are ready to open a collection point for the drugs within 24 hours of the outbreak, with three more to follow within 48 hours, and up to 30 more across the county if needed.
But health chiefs are warning that residents must not become complacent and should be prepared for when the disease does strike.
There has still not been an outbreak of swine flu in Norfolk, although there has been one case in Lowestoft. But the risk of new cases is higher this week as people have just returned from half-term holidays to affected countries, particularly Mexico and the United States.
Leading public school Eton is closed this week because of an outbreak, and the Health Protection Agency says there has been “widespread transmission” between pupils at the school.
So far the disease has been similar to normal seasonal flu in severity. But because the elderly have been relatively little affected, the 229 confirmed cases in Britain so far have not caused many complications.
John Battersby, NHS Norfolk's director of public health, said: “There will come a time when we see cases within Norfolk. Our health teams are prepared, and we are working closely and effectively with other agencies, but we need the public to keep themselves aware and to make their own preparations.
“One of the biggest problems we could face is people becoming complacent about swine flu, and thinking that none of these messages relate to them. They relate to all of us. This is not about panic, it's about sensible preparation.”
Most of the cases so far have been in the under-50s, with ages 15-20 the most affected. Few elderly people have caught the disease. Dr Battersby said they would have some immunity developed from being exposed to similar strains in the
past.
He said the Health Protection Agency's modelling suggested the disease would “burn for a long time” with a steady flow of cases, rather than a surge or the disease disappearing altogether.
Taking the Tamiflu delivery posed unusual logistical problems. Dr Battersby said: “We were asking for information about sheer volume and didn't get particularly accurate information. Then it arrived and it was a 40-tonne articulated lorry crammed full. The logistics of moving it around were quite considerable.
“It comes on pallets. A lot of pharmacy doorways aren't designed to take stock on pallets, so it has to be unloaded to get it off.”
If there is an outbreak, the drugs will be collected by “flu friends” of those affected, rather than by the ill person, to avoid spreading it. The first collection centre to open in the county is planned for Norwich and the first in Yarmouth and Waveney is due to be Lowestoft, but health trusts are trying to keep it flexible so they can react to the outbreak as it happens.
Alistair Lipp, director of public health at NHS Yarmouth and Waveney, said: “We are developing plans to respond to increasing numbers of swine flu cases. We hope that won't happen.
“We have stocks of face masks and stocks of antivirals and plans to distribute them. We are training staff to run the centres. GPs are working together and as they get busier they will support each other, and we will support the out-of-hours service too.”
A vaccine is being developed and there are likely to be two immunisation programmes this winter - one for seasonal flu as usual and one for swine flu - which may be targeted at different groups.
People are being asked to choose a “flu friend” who can help if they become ill, and to remember the importance of good hygiene in stopping the disease.
Anyone concerned that they may be displaying swine flu symptoms or have recently come into close contact with someone who has, is advised to stay at home and contact their GP by phone or seek advice from NHS Direct on 0845 4647.
|
|
Some people from Norfolk have already had swine flu from going on holiday abroad, two days feeling rum, few days more resting and then back to work. No tamiflu needed. Spoke to one this morning. Thats it. Still think your scarmongering mad. I'm more worried about the lack of lolly in the UK's pension pots than Tamiflu, or gas supplies next winter.
|
|
|
|
|
Report
|
|
|
|
|
02/06/2009, 11:16 PM
|
Hide the decline
Joined on 12/03/2008
Posts 1,356
|
|
|
|
| GreenBlue wrote: | | ironsmad wrote: | | ironsmad wrote: | | GreenBlue wrote: |
| ironsmad wrote: | Try reading what Dr John said Bluebottle
It is very early days at the moment, so it is important to avoid speculation. What we know about this particular strain is it does seem to be spreading rapidly, but outside Mexico cases the cases have been relatively mild and I'm not aware of any deaths.
“So if that continues, then I guess we can anticipate it will spread to the UK at some stage and we will get people infected with a similar, relatively mild illness.
“But in the last few days it has become clear things can change and that is one of the first elements of uncertainty that goes with a potential pandemic.”
No safe vaccine exists for swine flu, and Dr Battersby believes one is at least three or four months away.
Paul Hunter was more on the ball
Paul Hunter, professor of health protection at the University of East Anglia, said he was concerned just how many cases had been reported in other countries since the Mexican outbreak.
He said: “Although it is always very difficult to predict the course of an outbreak this early on, the fact that cases are already being reported from around the world is of concern. This suggests to me that the virus certainly does have epidemic potential.”
http://www.cdc.gov/swineflu/masks.htm?s_cid=tw_epr_76
The outbreak of disease in people caused by a new influenza virus of swine origin continues to grow in the United States and internationally. Today, CDC reports additional confirmed human infections, hospitalizations and the nation’s first fatality from this outbreak. The more recent illnesses and the reported death suggest that a pattern of more severe illness associated with this virus may be emerging in the U.S. Most people will not have immunity to this new virus and, as it continues to spread, more cases, more hospitalizations and more deaths are expected in the coming days and weeks.
Protection: Karya Lustig, a trainer at California’s La Clinica de la Raza, shows clerks how to use protective respiratory masks
Masks are going like hotcakes in Britain, the head bags tend to get steamed up.
|
|
Try rereading Doc Battersby "so it is important to avoid speculation"
That's what you are doing mad, and scaremongering spectulation at that. |
|
http://video.google.co.uk/videoplay?docid=-8674401787208020885
|
|
|
| Boxes of Tamiflu |
01 June 2009 10:30
Try rereading Doc Battersby "so it is important to avoid speculation"
That's what you are doing mad, and scaremongering spectulation at that.
Who's scaremongering now, a not so secret location if you enlarge the pic on the labels. its just off the **** road.
Norfolk’s population was 840,700 in mid-2007, an increase of around
8,200 from mid-2006, as against an increase of 6,500 over the
previous twelve months;
Not enough anti-viral for the population for Norfolk,come the flu season.
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
MedImmune, the global biologics unit of AstraZeneca, announced today that it has submitted a Marketing Authorisation Application (MAA) for its nasal spray live attenuated influenza vaccine (LAIV), which is now being reviewed by the European Medicines Agency (EMEA). The proposed indication in the MAA is for prevention of seasonal influen
MedImmune | Press Room | Press Room Overview
GAITHERSBURG, Md., June 1 /PRNewswire/ -- MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has awarded the company a contract to manufacture monovalent (single-strain) live attenuated influenza vaccine for Novel Influenza A (H1N1) to vaccinate priority populations identified by HHS in the National Strategy for Pandemic Influenza. An initial order of $90 million of vaccine has been placed, with the potential for additional orders.As a needle-free nasal spray, LAIV is well suited to facilitate mass vaccination . LAIV is different from the injectable influenza vaccine ("flu shot") in that it is a gentle mist sprayed into the nose, where the influenza virus usually enters the body. It contains live vaccine virus strains that are weakened so as not to cause the flu
Boxes of the antiviral drug Tamiflu pack a Norfolk warehouse almost to the ceiling, ready for an outbreak of swine flu.
The warehouse, in a secret location in the county, contains 95,000 boxes of the drug, each enough for one person. They completely filled a 40-tonne articulated lorry when they arrived.
If there is an outbreak and more is needed, Norfolk can receive up to twice that amount again within days from a national distribution centre.
And health chiefs are ready to open a collection point for the drugs within 24 hours of the outbreak, with three more to follow within 48 hours, and up to 30 more across the county if needed.
But health chiefs are warning that residents must not become complacent and should be prepared for when the disease does strike.
There has still not been an outbreak of swine flu in Norfolk, although there has been one case in Lowestoft. But the risk of new cases is higher this week as people have just returned from half-term holidays to affected countries, particularly Mexico and the United States.
Leading public school Eton is closed this week because of an outbreak, and the Health Protection Agency says there has been “widespread transmission” between pupils at the school.
So far the disease has been similar to normal seasonal flu in severity. But because the elderly have been relatively little affected, the 229 confirmed cases in Britain so far have not caused many complications.
John Battersby, NHS Norfolk's director of public health, said: “There will come a time when we see cases within Norfolk. Our health teams are prepared, and we are working closely and effectively with other agencies, but we need the public to keep themselves aware and to make their own preparations.
“One of the biggest problems we could face is people becoming complacent about swine flu, and thinking that none of these messages relate to them. They relate to all of us. This is not about panic, it's about sensible preparation.”
Most of the cases so far have been in the under-50s, with ages 15-20 the most affected. Few elderly people have caught the disease. Dr Battersby said they would have some immunity developed from being exposed to similar strains in the
past.
He said the Health Protection Agency's modelling suggested the disease would “burn for a long time” with a steady flow of cases, rather than a surge or the disease disappearing altogether.
Taking the Tamiflu delivery posed unusual logistical problems. Dr Battersby said: “We were asking for information about sheer volume and didn't get particularly accurate information. Then it arrived and it was a 40-tonne articulated lorry crammed full. The logistics of moving it around were quite considerable.
“It comes on pallets. A lot of pharmacy doorways aren't designed to take stock on pallets, so it has to be unloaded to get it off.”
If there is an outbreak, the drugs will be collected by “flu friends” of those affected, rather than by the ill person, to avoid spreading it. The first collection centre to open in the county is planned for Norwich and the first in Yarmouth and Waveney is due to be Lowestoft, but health trusts are trying to keep it flexible so they can react to the outbreak as it happens.
Alistair Lipp, director of public health at NHS Yarmouth and Waveney, said: “We are developing plans to respond to increasing numbers of swine flu cases. We hope that won't happen.
“We have stocks of face masks and stocks of antivirals and plans to distribute them. We are training staff to run the centres. GPs are working together and as they get busier they will support each other, and we will support the out-of-hours service too.”
A vaccine is being developed and there are likely to be two immunisation programmes this winter - one for seasonal flu as usual and one for swine flu - which may be targeted at different groups.
People are being asked to choose a “flu friend” who can help if they become ill, and to remember the importance of good hygiene in stopping the disease.
Anyone concerned that they may be displaying swine flu symptoms or have recently come into close contact with someone who has, is advised to stay at home and contact their GP by phone or seek advice from NHS Direct on 0845 4647.
|
|
Some people from Norfolk have already had swine flu from going on holiday abroad, two days feeling rum, few days more resting and then back to work. No tamiflu needed. Spoke to one this morning. Thats it. Still think your scarmongering mad. I'm more worried about the lack of lolly in the UK's pension pots than Tamiflu, or gas supplies next winter. |
|
Its not me who's got a warehouse in Norwich full Tamiflu!!!!!!!!!
Swine flu: three in intensive care
Jun 2 2009
');
tm.siteLife.daapi.getArticle(
"21-100252-23772606",
function(article){
tm.siteLife.display.displayCommentCount(
article,
'sitelife-commentsWidget-top',
false,
'Comments',
true
);
}
);
})();//call anonymous function
//]]>
//
Two people have been admitted to intensive care with swine flu, making a total of three critically ill patients.
The
new cases are being treated at the Royal Alexandra Hospital in Paisley,
Renfrewshire, and include a 45-year-old man who is not thought to have
any other underlying health problems.
It came as the Health
Protection Agency (HPA) revealed that 61 more people in England were
confirmed with swine flu, bringing the total number affected in the UK
to 362.
The two patients in intensive care are in a "critical but stable" condition, said the Scottish Government.
Neither case is linked to any other previously known cluster of swine flu cases.
The
45-year-old man, from Paisley, is believed to be the first case in the
UK where someone has been admitted to intensive case without any
underlying health conditions. A 38-year-old woman from Glasgow is the
other case admitted to intensive care, although she did have previous
underlying health problems.
Last week a 38-year-old man, who also had other health problems, was admitted to intensive care at a hospital in Glasgow.
Scottish
Health Secretary Nicola Sturgeon confirmed the development as she
announced the total number of confirmed swine flu cases in Scotland had
increased by 23 to 65.
Ms Sturgeon said she understood concerns the public would have on hearing the latest developments.
"That's
entirely understandable," she said. "The fact remains that in the vast,
overwhelming majority of cases, people with this virus are experiencing
relatively mild symptoms, in some cases very mild."
|
|
|
|
|
Report
|
|
|
|
|
25/06/2009, 11:11 PM
|
Hide the decline
Joined on 12/03/2008
Posts 1,356
|
|
|
|
| ironsmad wrote: | |
With the A/H1N1/piggy flu due to knock the crap, out of Britain this coming Autumn .It all points to some little nasty man made bio/lab release.
Journalist Files Charges against WHO and UN for Bioterrorism and Intent to Commit Mass Murder
Specifically, evidence is presented that the defendants, Barack Obama,
President of the U.S, David Nabarro, UN System Coordinator for
Influenza, Margaret Chan, Director-General of WHO, Kathleen Sibelius,
Secretary of Department of Health and Human Services, Janet Napolitano,
Secretary of Department of Homeland Security, David de Rotschild,
banker, David Rockefeller, banker, George Soros, banker, Werner
Faymann, Chancellor of Austria, and Alois Stoger, Austrian Health
Minister, among others, are part of this international corporate
criminal syndicate which has developed, produced, stockpiled and
employed biological weapons to eliminate the population of the U.S. and
other countries for financial and political gain.
Charges filed with the 1st part translated into English « Case about Bird Flu
Manufactured Flu to kill us off,digging up corpse's to get the virus.
YouTube - Swine flu made in USA
|
|
|
|
|
Report
|
|
|
|
|
26/06/2009, 8:47 AM
|
Harvs
Joined on 17/04/2008
Posts 37
|
|
|
|
| ironsmad wrote: | | ironsmad wrote: | |
With the A/H1N1/piggy flu due to knock the crap, out of Britain this coming Autumn .It all points to some little nasty man made bio/lab release.
Journalist Files Charges against WHO and UN for Bioterrorism and Intent to Commit Mass Murder
Specifically, evidence is presented that the defendants, Barack Obama,
President of the U.S, David Nabarro, UN System Coordinator for
Influenza, Margaret Chan, Director-General of WHO, Kathleen Sibelius,
Secretary of Department of Health and Human Services, Janet Napolitano,
Secretary of Department of Homeland Security, David de Rotschild,
banker, David Rockefeller, banker, George Soros, banker, Werner
Faymann, Chancellor of Austria, and Alois Stoger, Austrian Health
Minister, among others, are part of this international corporate
criminal syndicate which has developed, produced, stockpiled and
employed biological weapons to eliminate the population of the U.S. and
other countries for financial and political gain.
Charges filed with the 1st part translated into English « Case about Bird Flu
Manufactured Flu to kill us off,digging up corpse's to get the virus.
YouTube - Swine flu made in USA
|
|
Or more likely, antigenic drift/shift in the flu virus, coupled with the high genetic mutation rate seen in all viruses. This can explain how two completely independent viruses can swap genetic information, thus explaining the formation of new flu viruses. I would think this is a more likely scenario, as opposed to global conspiracy theories. I suggest an immunology textbook, possibly Roitt's Essential Immunology, it gives a decent explanation of how pathogens mutate and adapt. On a side-note, the clinical trial evidence for Tamiflu suggests it isn't actually a particularly effective anti-viral. Must see if I can find the original papers on it.
|
|
|
|
|
Report
|
|
|
|
|
26/06/2009, 7:25 PM
|
Hide the decline
Joined on 12/03/2008
Posts 1,356
|
|
|
|
Thanks harvs for the info on the immly txtbook, I shall muse latters. I still go for the extreme greens who want, a reduction of the world population. Along with the globalist elite, who want a return to serfdom and world governance.
US develops lethal new viruses
29 October 03 : Exclusive from New Scientist Print Edition.
A scientist funded by the US government has deliberately created an
extremely deadly form of mousepox, a relative of the smallpox virus,
through genetic engineering.
The new virus kills all mice even if they have been given antiviral
drugs as well as a vaccine that would normally protect them.
The work has not stopped there. The cowpox virus, which infects a range
of animals including humans, has been genetically altered in a similar
way.
The new virus, which is about to be tested on animals, should be lethal
only to mice, Mark Buller of the University of St Louis told New
Scientist. He says his work is necessary to explore what bioterrorists
might do.
But the research brings closer the prospect of pox viruses that cause
only mild infections in humans being turned into diseases lethal even
to people who have been vaccinated.
And vaccines are currently our main defence against smallpox and its
relatives, such as the monkeypox that reached the US this year. Some
researchers think the latest research is risky and unnecessary.
"I have great concern about doing this in a pox virus that can cross
species," said Ian Ramshaw of the Australian National University in
Canberra on being told of Buller's work.
Ramshaw was a member of the team that accidentally discovered how to
make mousepox more deadly (New Scientist, 13 January 2001). But the
modified mousepox his team created was not as deadly as Buller's.
No rebound
Since then, Ramshaw told New Scientist, his team has also created more
deadly forms of mousepox, and has used the same method to engineer a
more deadly rabbitpox virus.
But this research revealed that the modified pox viruses are not
contagious, he says. That is good news in the sense that these viruses
could not cause ecological havoc by wiping out mouse or rabbit
populations around the world if they escaped from a lab.
However, this discovery also means some bioterrorists might be more
tempted to use the same trick to modify a pox virus that infects
humans. Such a disease, like anthrax, would infect only those directly
exposed to it. It would not spread around the world and rebound on the
attackers. But there is no guarantee that other pox viruses modified in
a similar way would also be non-contagious.
Ramshaw's team made its initial discovery while developing
contraceptive vaccines for sterilising mice and rabbits without killing
them. The researchers modified the mousepox virus by adding a gene for
a natural immunosuppressant called IL-4, expecting this would boost
antibody production.
Instead, the modified mousepox virus was far more lethal, killing 60
per cent of vaccinated mice. The addition of IL-4 seems to switch off a
key part of the immune system called the cell-mediated response.
Maximised production
Now Buller has engineered a mousepox strain that kills 100 per cent of
vaccinated mice, even when they were also treated with the antiviral
drug cidofovir. A monoclonal antibody that mops up IL-4 did save some,
however.
His team "optimised" the virus by placing the IL-4 gene in a different
part of the viral genome and adding a promoter sequence to maximise
production of the IL-4 protein, he told a biosecurity conference in
Geneva last week.
Buller has also constructed a cowpox virus containing the mouse IL-4
gene, which is about to be tested on mice at the US Army Medical
Research Institute of Infectious Diseases at Fort Detrick, Maryland.
Cowpox infects people, but Buller says the IL-4 protein is
species-specific and would not affect the human immune system. The
experiments are being done at the second-highest level of biological
containment.
Nine-eleven
Ramshaw says there is no reason to do the cowpox experiments, as his
group's work on rabbits has already shown the method works for other
pox viruses. While viruses containing mouse IL-4 should not be lethal
to humans, recombinant viruses can have unexpected effects, he says.
"You'd hope the combination remains mouse-specific."
Why his group's engineered viruses are not contagious is a mystery, he
says. It is not, for instance, because the host dies faster than usual,
taking the virus with it. But his findings could explain why pox
viruses containing IL-4 have never evolved naturally, even though the
viruses frequently pick up genes that affect their host's immunity.
Despite the concerns, work on lethal new pox viruses seems likely to
continue in the US. When members of the audience in Geneva questioned
the need for such experiments, an American voice in the back boomed
out: "Nine-eleven". There were murmurs of agreement.
|
|
|
|
|
Report
|
|
|
|
|
26/06/2009, 10:24 PM
|
Hide the decline
Joined on 12/03/2008
Posts 1,356
|
|
|
|
| Harvs wrote: | | ironsmad wrote: | | ironsmad wrote: | |
With the A/H1N1/piggy flu due to knock the crap, out of Britain this coming Autumn .It all points to some little nasty man made bio/lab release.
Journalist Files Charges against WHO and UN for Bioterrorism and Intent to Commit Mass Murder
Specifically, evidence is presented that the defendants, Barack Obama,
President of the U.S, David Nabarro, UN System Coordinator for
Influenza, Margaret Chan, Director-General of WHO, Kathleen Sibelius,
Secretary of Department of Health and Human Services, Janet Napolitano,
Secretary of Department of Homeland Security, David de Rotschild,
banker, David Rockefeller, banker, George Soros, banker, Werner
Faymann, Chancellor of Austria, and Alois Stoger, Austrian Health
Minister, among others, are part of this international corporate
criminal syndicate which has developed, produced, stockpiled and
employed biological weapons to eliminate the population of the U.S. and
other countries for financial and political gain.
Charges filed with the 1st part translated into English « Case about Bird Flu
Manufactured Flu to kill us off,digging up corpse's to get the virus.
YouTube - Swine flu made in USA
|
|
Or more likely, antigenic drift/shift in the flu virus, coupled with the high genetic mutation rate seen in all viruses. This can explain how two completely independent viruses can swap genetic information, thus explaining the formation of new flu viruses. I would think this is a more likely scenario, as opposed to global conspiracy theories. I suggest an immunology textbook, possibly Roitt's Essential Immunology, it gives a decent explanation of how pathogens mutate and adapt. On a side-note, the clinical trial evidence for Tamiflu suggests it isn't actually a particularly effective anti-viral. Must see if I can find the original papers on it.
|
|
One of the team involved in the trials of Tami flu, also thinks that this virus is a Lab job. That has been released/escaped ......
Tamiflu Developer: Swine Flu Could Have Come From Bio-Experiment Lab - ABC News
Adrian Gibbs, a scientist on the team that was behind the development
of Tamiflu, says in a report he is submitting today that swine flu
might have been created using eggs to grow viruses and make new vaccines, and could have been accidently leaked to the general public.
|
|
|
|
|
Report
|
|
|
|
|
27/06/2009, 11:37 AM
|
GreenBlue
Joined on 01/06/2008
Posts 1,598
|
|
|
|
| ironsmad wrote: | | Harvs wrote: | | ironsmad wrote: | | ironsmad wrote: | |
With the A/H1N1/piggy flu due to knock the crap, out of Britain this coming Autumn .It all points to some little nasty man made bio/lab release.
Journalist Files Charges against WHO and UN for Bioterrorism and Intent to Commit Mass Murder
Specifically, evidence is presented that the defendants, Barack Obama, President of the U.S, David Nabarro, UN System Coordinator for Influenza, Margaret Chan, Director-General of WHO, Kathleen Sibelius, Secretary of Department of Health and Human Services, Janet Napolitano, Secretary of Department of Homeland Security, David de Rotschild, banker, David Rockefeller, banker, George Soros, banker, Werner Faymann, Chancellor of Austria, and Alois Stoger, Austrian Health Minister, among others, are part of this international corporate criminal syndicate which has developed, produced, stockpiled and employed biological weapons to eliminate the population of the U.S. and other countries for financial and political gain.
Charges filed with the 1st part translated into English « Case about Bird Flu
Manufactured Flu to kill us off,digging up corpse's to get the virus.
YouTube - Swine flu made in USA
|
|
Or more likely, antigenic drift/shift in the flu virus, coupled with the high genetic mutation rate seen in all viruses. This can explain how two completely independent viruses can swap genetic information, thus explaining the formation of new flu viruses. I would think this is a more likely scenario, as opposed to global conspiracy theories. I suggest an immunology textbook, possibly Roitt's Essential Immunology, it gives a decent explanation of how pathogens mutate and adapt. On a side-note, the clinical trial evidence for Tamiflu suggests it isn't actually a particularly effective anti-viral. Must see if I can find the original papers on it.
|
|
One of the team involved in the trials of Tami flu, also thinks that this virus is a Lab job. That has been released/escaped ......
Tamiflu Developer: Swine Flu Could Have Come From Bio-Experiment Lab - ABC News
Adrian Gibbs, a scientist on the team that was behind the development of Tamiflu, says in a report he is submitting today that swine flu might have been created using eggs to grow viruses and make new vaccines, and could have been accidently leaked to the general public.
|
|
Mad you've just spun this more than Shane Warne on a sticky turning wicket!!!!!
Adrian Gibbs, a scientist on the team that was behind the development of Tamiflu, says in a report he is submitting today that swine flu might have been created using eggs to grow viruses and make new vaccines, and could have been accidently leaked to the general public.
"It might be some sort of simple error that's not being recognized," Gibbs said on ABC's "Good Morning America."
In an interview with Bloomberg Television, Gibbs admitted there are other ways to explain swine flu's origin.
"One of the simplest explanations if that it's a laboratory escape, but there are lots of others," he said.
|
|
|
|
|
Report
|
|
|
|
|
27/06/2009, 2:19 PM
|
Harvs
Joined on 17/04/2008
Posts 37
|
|
|
|
| GreenBlue wrote: | | ironsmad wrote: | | Harvs wrote: | | ironsmad wrote: | | ironsmad wrote: | |
With the A/H1N1/piggy flu due to knock the crap, out of Britain this coming Autumn .It all points to some little nasty man made bio/lab release.
Journalist Files Charges against WHO and UN for Bioterrorism and Intent to Commit Mass Murder
Specifically, evidence is presented that the defendants, Barack Obama, President of the U.S, David Nabarro, UN System Coordinator for Influenza, Margaret Chan, Director-General of WHO, Kathleen Sibelius, Secretary of Department of Health and Human Services, Janet Napolitano, Secretary of Department of Homeland Security, David de Rotschild, banker, David Rockefeller, banker, George Soros, banker, Werner Faymann, Chancellor of Austria, and Alois Stoger, Austrian Health Minister, among others, are part of this international corporate criminal syndicate which has developed, produced, stockpiled and employed biological weapons to eliminate the population of the U.S. and other countries for financial and political gain.
Charges filed with the 1st part translated into English « Case about Bird Flu
Manufactured Flu to kill us off,digging up corpse's to get the virus.
YouTube - Swine flu made in USA
|
|
Or more likely, antigenic drift/shift in the flu virus, coupled with the high genetic mutation rate seen in all viruses. This can explain how two completely independent viruses can swap genetic information, thus explaining the formation of new flu viruses. I would think this is a more likely scenario, as opposed to global conspiracy theories. I suggest an immunology textbook, possibly Roitt's Essential Immunology, it gives a decent explanation of how pathogens mutate and adapt. On a side-note, the clinical trial evidence for Tamiflu suggests it isn't actually a particularly effective anti-viral. Must see if I can find the original papers on it.
|
|
One of the team involved in the trials of Tami flu, also thinks that this virus is a Lab job. That has been released/escaped ......
Tamiflu Developer: Swine Flu Could Have Come From Bio-Experiment Lab - ABC News
Adrian Gibbs, a scientist on the team that was behind the development of Tamiflu, says in a report he is submitting today that swine flu might have been created using eggs to grow viruses and make new vaccines, and could have been accidently leaked to the general public.
|
|
Mad you've just spun this more than Shane Warne on a sticky turning wicket!!!!!
Adrian Gibbs, a scientist on the team that was behind the development of Tamiflu, says in a report he is submitting today that swine flu might have been created using eggs to grow viruses and make new vaccines, and could have been accidently leaked to the general public.
"It might be some sort of simple error that's not being recognized," Gibbs said on ABC's "Good Morning America."
In an interview with Bloomberg Television, Gibbs admitted there are other ways to explain swine flu's origin.
"One of the simplest explanations if that it's a laboratory escape, but there are lots of others," he said. |
|
Not to mention that the simplest explanation is that it was a random natural occurrence. The link provides a pathetic interview, with no scientific reasons given, merely speculation. Unfortunately, some scientists just enjoy their moment on TV, look at Andrew Wakefield and how he handled the "MMR causes autism" affair. No actual evidence, but a personal vendetta coupled with a "look at me, look at me" attitude!
|
|
|
|
|
Report
|
|
|
|
|
27/06/2009, 11:25 PM
|
Hide the decline
Joined on 12/03/2008
Posts 1,356
|
|
|
|
For this virus to have random natural occurrence, jumping back and forth ,bird,pig,human...Yet no evidence of pigs in Mexico of having swine flu, no mass culling of pigs in Mexico or the US. Only Egypt have done any mass culling. Adrian Gibbs is at the top of his profession, has nothing to gain from suggesting Bio/Lab escape. The vast companies like Bayer will be the one's minted up. It has to myself and many others, the hall marks of classic EU/USA/UN sting. How far these global elite want to run with their enslavement ,control of world population is any one's guess.
 |
 |
|
 |
 |
|
 |
|
|
|
Updated 11/07/02
Please use the menu below to jump to a topic:
AIDS & HIV Articles
-----------------------------------------------------
THE GENESIS &
CHRONOLOGY OF THE DEVELOPMENT OF HIV/AIDS :
New genocidal
AIDS vaccine experiments
Side Effects
of AIDS Drugs and Lower Prices for Africa
Study: AIDS Devastating
Africa
Early Hepatitis
B Vaccines and the “Man-Made Origin of HIV/AIDS:
U.S. GAO Investigated
the Wrong AIDS Origin Theory
Polio, Hepatitis
B and AIDS
The US Shadow Government
Perspectives
on a Possible Vaccine Induced Pandemic
AIDS: Genocial Germ
for a New World Order?
False Hope or Guilty
Conscious?
<< Return
to AIDS & HIV Press Releases
 |
| FEATURED
ARTICLE
Early
Hepatitis B Vaccines and the “Man-Made” Origin
of HIV/AIDS
by
Leonard G. Horowitz, D.M.D., M.A., M.P.H.
This
article regards a matter of global urgency transcending better
known AIDS threats. It describes a universal challenge posed
by ever increasing numbers of plagues predicted to depopulate
at least half of the world’s current human inhabitants
within two generations. This documented science virtually
proves, through the process of elimination and a review of
the most updated evidence, the origin of HIV/AIDS as an iatrogenic
(i.e., man-made) outcome of specific vaccination experiments.
Considered
reflection on this AIDS science, along with the sociopolitical
correlates and antecedents of this current catastrophe, reveals
the likelihood that myriad other immune
dysfunctions, autoimmune diseases, and cancers, including
leukemias, lymphomas, sarcomas, and other ailments linked
to viral infections, have resulted from previously engineered
microbes that have by accident or intent found their way from
cancer virus laboratories into humanity’s bloodstream
by way of the most trusted public health preventative—vaccinations.
If
what you are about to read is true, and each point is precisely
stated and meticulously documented, beyond extensive depopulation,
humanity’s very survival may hinge on this recognition,
its implications, and our considered response. Especially
relevant, when reflecting on the following facts, is the wisdom
addressed by the late World Health Organization (WHO) AIDS
czar, Dr. Jonathan Mann, whose life ended tragically on Flight
111 enroute to a European AIDS conference. “More than
a medical scientific problem,” Dr. Mann said, “AIDS
is a sociopolitical imposition.”
Background
AIDS
is undoubtedly “man-made.” We can now assert this
“very apparent iatrogenic origin,” versus the
“theoretic iatrogenic origin” of HIV/AIDS because
of the rapidly increasing, now substantial, scientific support
for this conclusion. Currently, international scientific consensus
among leading investigators in this field, many of whose works
and words are excerpted below, holds that HIV/AIDS originated
from one or more extraordinary man-made, not natural, events
dating back to the early to mid-1970s. Especially implicated
in initiating the AIDS pandemic, according to many scientists
and scholars, was the hepatitis B vaccine as detailed in the
following pages.
This
may come as a surprise, or even quite a shock, to most people
since the mainstream media and most respected medical journals
have yet to herald the following knowledge. As a result most
“authorities” still issue false and misleading
claims such as: 1) “the HB vaccine theory of HIV/AIDS
origination has been discussed, debated, and dismissed by
an overwhelming majority of the HIV/AIDS research community;”
2) “People who claim that AIDS was man-made provide
false information and hearsay;” 3) “It is sad
that public attention and resources are diverted to attend
to such unscientific dribble;” 4) “Man-made origin
of AIDS vaccine proponents do severe damage to the public
health community and vaccination efforts;” and 5) “Those
that advance man-made theories of AIDS have financial motives,”
as though there were no financial interests on the other side
of the debate.
As
a pro bono consultant contacted recently by Amnesty International
(AI) members who desired to advance a resolution for the global
organization to investigate this HB vaccine thesis, I was
appalled by the amount of resistance and politicking performed
by members of AI’s so-called “HIV/AIDS Task Force”
which sought $1 billion of relief for human rights violations
associated with HIV/AIDS from the U.S. Government. These funds,
the Task Force reported, were urgently needed to buy drug–cocktails
for persons with HIV/AIDS. Each of the five claims cited above
were issued by members of this Task Force completely ignorant
of the following science.
With
regard to the first offensive claim, as the sole author of
“Polio, hepatitis B and AIDS: an integrative theory
on a possible vaccine induced pandemic” published by
Harcourt Publishers, Ltd. of London in the esteemed international
journal of Medical Hypothesis,2
this well-focused thesis has never been “discussed,
debated,” nor “dismissed” by any consensus
in any official capacity. Although Black Americans have been
polled regarding the origin of HIV/AIDS being man-made,3
there has never been a published polling of the scientific
community in this regard, and certainly not one regarding
the HB hypothesis advanced below.
HIV/AIDS
Origin Misconceptions Versus Science
Opponents
of iatrogenic (or “man-made”) theories of AIDS
have routinely confused hearsay and sporadic media propaganda
with hard science, such as that “discussed, debated”
and not “dismissed” recently at the Royal Society
of London’s inquiry into the origin of this pandemic.
They exclusively focused on the theory that contaminated polio
vaccines triggered the HIV/AIDS pandemic.4
These proceedings were published in 2001. Quotes relevant
to reasoned consideration of this unique/yet-to-be-tested
hepatitis B vaccine theory of HIV/AIDS follow. These statements
were made by featured presenters, all recognized leaders in
this multidisciplinary field discussing the polio vaccine
theory of AIDS origination. The first of these quotes is especially
relevant to
proposed investigations:
“There
should be an investigation by an international committee mostly
composed of non-medical people concerning how a rather obvious
and plausible theory [of AIDS’s origin from contaminated
vaccines] came to be scorned and restricted from publication
for so long, especially when important consequences regarding
mankind’s worst epidemic, and even more important consequences
for other possibly even worse that may be following, hang
in the balance. As a corollary it should be studied why the
hypothesis had to be promoted mainly by outsiders to science
and medicine. The ressures towards investigation (and non-investigation)
that emanate from huge drug companies and their influence
in slanting research in subtle ways should also be examined,
as should the role of journals and peer review in potentially
obstructing publications of controversial kinds.” W.D.
Hamilton,5 quoted by Julian Cribb
in “The origin of acquired immune deficiency syndrome:
can science afford to ignore it?” Phil. Trans. R. Soc.
Lond. B (2001) 356:935-938.
“Faced
with the terrible burden of AIDS, stories that HIV was introduced
into Africa from the West by an accident such as OPV [oral
polio vaccine] or intentionally by the USA Central Intelligence
Agency (CIA) have gained widespread credence. . . . Nevertheless,
because natural transmission repeatedly occurs, albeit on
rare occasions, does not mean that contamination of a vaccine
could not have been the route on another occasion. As with
other infections, e.g., hepatitis B virus,natural and iatrogenic
transmissions of retroviruses are not mutually exclusive.” Weiss,
RA6
Despite
studies that have advanced evidence suggesting an earlier
than 1970 origin of HIV/AIDS,7-9
“[t]he fact that there were ten or so synchronous but
distinguishable African epidemics is a definitive feature
of AIDS for which the natural transfer theory [e.g., the “cut
hunter transfer”] gives no convincing account. . . .
To summarize these findings regarding the relatively large
number of distinct group M subtypes: no set of likely natural
conditions . . . will adequately simulate so many as ten distinguishable
subtypes in a complex star-like configuration . . . . [T]he
onus is upon the supporters of the natural [not iatrogenic]
theory to account for the unexpectedly large number of HIV-1
subtypes. Exponential growth of the epidemic(s) is not by
itself a satisfactory explanation (Hahn et al. 2000). . .
. The likeliest source of the multiple subtypes and the synchronization
of their conspicuous diversification is a punctuated origin
[i.e., an iatrogenic event]. . . . ![Idea [I]](/cs/emoticons/emotion-55.gif) t is not far-fetched
to imagine the ten or so clades deriving from a single animal
(perhaps immunosuppressed and possessing a swarm of variants)
[as might have been the case with chimpanzees used in the
process of vaccine manufacture] or from a few animals that
might have belonged to a single troop or might have been gang-caged
together. The number of animals required is secondary to the
extent of variation in the source at the time of the zoonotic
[i.e., transfer of the virus between species] or iatrogenic
event. The [vaccine] hypothesis makes a case for such a punctuated
origin . . .” Myers G, et al. 10
“We
conclude that SIV cannot become a zoonosis, but requires adaptive
mutations to become HIV. Some modern event must have aided
in the transition of SIV to HIV. Our research indicates that
serial passage of partially adapted SIV between humans could
produce the series of cumulative mutations sufficient for
the emergence of epidemic HIV strains . . . We conclude that
increased unsterile injecting in Africa during the period
1950-1970 provided the agent for SIV human infections to emerge
as epidemic HIV in the modern era.” Drucker E, et al.11
I
might interject at this point that this conclusion by Drucker
et al, although seriously undermining natural evolution theorists,
reflects a myopic arrogance unbecoming to their otherwise
reasonable hypothesis. Their conclusion neglects the risks
inherent in the hepatitis B vaccine manufacturing and testing
process as detailed below consistent with the analyses of
Myers et al.10 Obviously, all of
the above authoritative statements contradict “common
knowledge.” The consensus of scientists at this historic
British AIDS origin conference favored additional investigations
into possible iatrogenic sources of the HIVs.
The
1959 HIV Sequence Discovery
In
the interest of facilitating progress on this issue, much
publicity has been given to the notion that HIV was discovered
in a 1959 blood sample from Leopoldville, Zaire;9
and that scientific consensus holds 1931 as the approximate
date of HIV origination.7 These
superstitions have led to common, yet false, declarations
that HIV/AIDS originated well before the polio vaccination
era and the Special Virus Cancer Program (SVCP) that much
evidence below links to the “punctuated origin”
of AIDS.
For
the record, according to the authors of the 1959 discovery,
they never found, nor alleged to have found, HIV, or anything
like a full virus. According to these authors, even “attempts
to amplify HIV-1 fragments of >300 base pairs (bp) were
unsuccessful, . . . However, after numerous attempts, four
shorter sequences were obtained” that only represented
small portions of two of the six genes of the complete AIDS
virus.9
This
is why Gao et al, referred to the 1959 sequences as “the
oldest trace of the AIDS pandemic . . . although the precise
timing and circumstance of early events in the SIVcpz/HIV-1
zoonosis remain obscure.”22
[Editor’s note for the lay reader, “SIVcpz”
is short for “simian immunodeficiency virus from the
chimpanzee.” This is know to be the closest viral relative
to the human AIDS virus, HIV-1.]
Unfortunately,
regarding the 1959 sequences, Zhu et al., left much room for
misinterpretation if not wild speculation by stating that
given the “‘starburst phylogeny,’ HIV-1
was probably introduced into humans shortly before that time
frame, about a decade or two earlier than previously estimated.
. . .” 10 (Emphasis added.)
They speculated the zoonosis might have occurred “considerably
earlier than the late 1940s.” Obviously, this account
is irrelevant to “the extraordinary synchrony in the
1970s of ten or more distinguishable epidemics” discovered
by Myers et al. 10 Therefore, this
later group of researchers concluded that, with the exception
of the 1959 sequences suggesting viral ancestry, “Clinical,
serological and molecular retrospective studies have all failed
to produce any evidence of AIDS or HIV prior to the 1970s.”
10 (Emphasis added.) As Myers et
al., had initially advanced, the early to mid-1970s “Big
Bang” origin of HIV/AIDS is further supported by most
recent scientific evidence.10
As
if repeating false assumptions would alter historic and scientific
facts, many contemporary investigators, like those representing
AI’s HIV/AIDS Task Force, continue to imply the SIV
to HIV zoonosis occurred on or before 1959. Many natural evolution
theory evangelists continue to cite the now disproven “cut
hunter” theory to explain the origin of the pandemic.8,22 Reflecting
on Zhu et al’s position, however, they simply concluded
that the major-group viruses that dominate the global AIDS
pandemic at present shared a common ancestor in the 1940s
or the early 1950s. However, given confounding factors, including
the likelihood of viral gene recombination during the manufacture
and testing of the HB vaccine, like Korber et al.’s
speculation discussed in the next section, the 1959 “isolate”
may hold little, if any, relevance in determining the origin
of HIV/AIDS. 10
Suffice
it to say, no one has ever found a virus predating the SVCP
and the late 1970s.11 At best they
found fragments of what may have been the complete virus,
but more likely pieces of a progenitor virus they called “a
common ancestor” that dated back to “the 1940s
or the early 1950s.” These and other portions of this
“common ancestor” may have existed for centuries
if not millennia. Again, this evidence is rrelevant when considering
the 1970s “punctuated [iatrogenic] event” recently
determined to be undisputable scientific fact.
More
importantly, as Zhu and Ho et al., concluded, “the role
of large-scale vaccination campaigns, perhaps with multiple
uses of non-sterilized needles, should be carefully examined,
. . .” as contributing to the sudden emergence of HIV/AIDS
in North America and Africa simultaneously during the late
1970s.9,11
The
1931 AIDS Origin Assumption and Viral Recombination
Regarding
the 1931 estimated date of HIV’s origin advanced by
Korber et al.7 (i.e., “somewhere
between 1910 and 1950”), a critical examination of these
authors’ methods reveals problems. Largely speculative
due to their use of a confounding-factor-liable computer model,
Korber and colleagues noted their limitations. They stated
their finding(s) regarding the 1931 genetic projection, that
precludes various vaccine-induced pandemic theories, might
be wrong if viral recombination(s) had occurred. They most
certainly did in the evolutionary process of SIV to HIV according
to most cientists.10,13
Yet, despite these facts, iatrogenic theory opponents who
have secured a gross burden of proof” advantage in the
AIDS origin debate,20 repeatedly
reference this group’s work, along with the frequently
misrepresented work of Zhu, et al.9
concerning the 1959 sequence discovery.22
Again,
the “punctuated origin” of HIV/AIDS determined
by Myers et al., can only explain the nearly simultaneous
emergence of ten separate, though related, AIDS epidemics
in Africa during the early 1970s, that were well established
by 1976.10
Lending
further credence to the theory that early hepatitis B vaccine
trials provided the “punctuated event,” Korber
et al wrote of anticipated errors in their 1931 determination
using linear or recombinant evolutionary models due to “unnatural”
or iatrogenic events inciting viral recombination. They wrote
, “If there was a concentration of such recombinants
during just one period of sampling, the effect on the timing
estimate would be unpredictable.” 7
Thus,
if the “punctuated origin event” advanced by Myers
et al,10 had been the passage of
HB virus from polio vaccinated humans to chimpanzees then
back to humans, with the additional risk of recombination
from pooling hundreds of infected serum samples prior to additional
viral recombinant transfers via the HB vaccines given to human
subjects in New York City and sub-Saharan Africa, then this
might best explain the origin of HIV/AIDS and render Korber
et al’s 1931 projection inconsequential. As detailed
in the next section, this is precisely the thesis advanced
by Horowitz.2,13
In
summary, the determinations reached by Korber et al.,7
and Ho et al.,9 of possible dates
for the origin of HIV-1, 1931 and 1959 respectively, have
been adequately clarified elsewhere.10
“The authors themselves acknowledge, the super-computer-based
study cannot tell whether this hypothetical 1930 virus was
in humans or animals and so do not show when zoonosis occurred.”
7,10
Myers
et al. further qualified: “If PIV [primate immunodeficiency
virus] was in humans in the first half of the 20th century,
it may be estimated, given the assumptions of the look-back
analysis, that the ancestral HIV-1 group M virus arose at
1930 plus or minus 20 years.” Conversely, if PIV was
not in humans in the first half of the 20th century, then
the Korber et al analysis holds little, if any, value in-so-far-as
determining a date or origin of the HIVs and AIDS. 7,10
The
Earliest Hepatitis B Vaccines and The Origin of AIDS
If
early polio vaccines had not triggered the origin of HIV/AIDS
as scientific consensus now holds,6
then some other, chimpanzee-related, “iatrogenic event”
must be available to explain the staggering array of deadly
recombinants that were proven by Myers et al to have arisen
virtually simultaneously during the early to mid-1970s.10,21
In this regard, even more neglected, and perhaps more relevant
than the OPV theory of AIDS, is the hepatitis B (HB) vaccine
hypothesis.2,13,23
According
to scientific records,2 African
chimpanzees were used in the manufacture of the HB vaccines
during the early 1970s. Additional documents prove that human
HB viruses cultured in vivo in chimpanzees were returned to
humans whose infected blood serum was then pooled to develop
four different strains of experimental HB vaccine pilot tested
between 1970 and 1975 in New York City and central Africa.
This HB vaccine theory of HIV zoonosis proposes that endogenous,
or more likely exogenous, progenitor viruses were activated24
when serially transmitted from humans to chimpanzees, then
back to humans. Subsequently, pooled blood serum containing
HB surface antigen and/or live virions, a milieu ripe for
viral recombination, was used to develop the four suspected
vaccines administered to New York’s gay population and
simultaneously to sub-Saharan Africans. Besides the phylogenetic
evidence cited above, epidemiological evidence also supports
this HB vaccine theory of HIV/AIDS origination.
Figure
1 is derived from Higginson and Muir’s report on cancer
studies conducted by the International Agency for Research
in Cancer (IARC) in collaboration with the National Cancer
Institute (NCI).25 Figure 2 derives
from this data superimposed on a map of HIV-1 seroprevalence
in Africa reported by the U.S. Department of Commerce in a
publication discussing desirable depopulation associated with
HIV/AIDS.26 Additional evidence
here was supplied in the chronology of the early hepatitis
B vaccine trials compiled by Goodfield. 27
The two maps, juxaposed, show a striking correlation between
hepatitis B vaccine and liver cancer experiments conducted
in Africa during the early 1970s, and the countries in central
and southern Africa with the high est HIV-1 seroprevalence
rates by 1994. The black squares indicate areas participating
in the HB cancer virus research and vaccine trials.
It
should also be noted that Mozambique has one of the highest
rates of HIV-2, which was allegedly discovered by Essex et
al.,28 in Senegalese female prostitutes
years after the African hepatitis B vaccination pilot studies
began. Due to their state-authorized employment and high risk
for infection, Senegalese female prostitutes were required
to receive hepatitis B vaccinations for relicensure. That
Essex et al. found SIVagm, a documented vaccine contaminant,
in the blood of these human subject, is additionally compelling
evidence in support of the HB vaccine AIDS origination theory.29
In
brief, a well documented, theoretically viable, and generally
neglected evolutionary route of SIVagm to HIV-1 zoonosis sequentially
involves: 1) Polio vaccine recipients
worldwide, including gay men in New York, and Blacks in Central
Africa, were exposed to simian viruses including SV40, SFR
(Simian Foamy Retroviruses containing reverse transcriptase),
SIVagm, and perhaps others from the mid-1950s, through at
least the 1960s;2,4 2) Between 1965 and 1970, researchers
in NYC “isolated” and then inoculated the MS-2
strain of HB virus into the above cited New York and African
HB vaccine study “volunteers.”2,30
3) Human derived HB viruses, and
potentially activated retroviral sequences, were then transferred
to chimpanzees, then back again to humans in NYC and central
Africa during the development and testing of four genetically
altered subtypes of the pre-1975 experimental HB vaccine.32,33
HIV-1 progenitor contamination, recombination, and/or transmission
risks were likely increased during this process by: a) human
incubation for more than a decade of polio vaccine contaminants
and recombinants including SV40, SFR, and possibly SIVagm;
b) the pooling of infected blood serum donated by hundreds
of gay American and Black African polio vaccine recipients
who had subsequently received injections with chimpanzee cultured
strains of HB virus; c) the biohazardous laboratory conditions
and viral containment problems reported by the HB vaccine
investigators and their affiliates; and finally 5)
The four pooled serum-derived HB vaccines that were administered
to thousands of test subjects by 1975, primarily gay males
in NYC and central African Blacks. This series of events provides
the best explanation for an early to mid-1970s “punctuated
origin event” most precisely fitting the etiological
determinations of the HIV-1/AIDS pandemic.10
Again,
it should be noted that the African “volunteers”
inhabited a geographic area consistent with the highest rates
of HIV-1 seroprevalence. Among the nations where rates are
highest, HB studies were conducted in: Senegal, Cote d’Ivoire,
Uganda, Kenya, Swaziland, and the northeastern part of South
Africa. According to circumstantial evidence, eastern Zaire
bordering the West Nile region of northwest Uganda also hosted
such trials.2,25-27
Historic
Precedence for the HB Vaccine Hypothesis
There
is historic precedence for this precise HB thesis. According
to Beale, the risk of HB viruses contaminating human blood
serum and subsequent vaccinations was determined as early
as 1942. Then, more than 62 deaths and 28,500 cases resulted
from serum HB contaminated yellow fever vaccines.31
According
to Hilleman, early yellow fever vaccines also delivered leukemic
retroviruses to human populations due to caged animal and
laboratory contaminations and concomitant vaccine transmissions.13
Dr.
Hilleman additionally reinforced this “punctuated origin”
thesis by describing the risks he encountered by importing
contaminated African sub-human primates for vaccine research
and development at the Merck pharmaceutical company. Between
the late 1950s through the 1970s, Dr. Hilleman told Harvard
medical historian Edward Shorter in 1987, “I brought
African greens in. I didn’t know we were importing AIDS
virus at the time.”13
Given
these statements of fact, it is reasonable to suggest, as
stated above, the earliest HB vaccine pilot studies may have
activated an endogenous or exogenous HIV-related retroviral
gene in one or more of the primates,24
fulfilling the “starburst phylogeny” antecedents
advanced by Myers et al.10
During
the Royal Society’s symposium on the origin of AIDS,
Hooper’s 1950s OPV/AIDS hypothesis was largely rebuked
because he failed to establish the use of chimpanzees by the
Wistar Institute in the production of the suspected OPV.18
Moreover, this vaccine was not given selectively to New York’s
gay male population. Curiously, Merck’s early 1970s
hepatitis B vaccine trials that did involve gay men in NYC,
and Blacks in central Africa, partially prepared in Litton
Bionetics (LB) exported/Merck imported African chimpanzees,
ironically went without mention.
“Burden
of Proof” and the Origin of AIDS
The
most vocal opponent of the OPV and HB vaccine theories of
HIV/AIDS origination is Dr. John Moore, affiliated with Rockefeller
University’s Aaron Diamond Research Center in New York.
As
reported in Medical Hypothesis, following a presentation advancing
the HB vaccine theory of HIV/AIDS at the XI International
Conference on AIDS, in 1996, Dr. Moore flippantly rebuked
this thesis in the Canadian press. A few years later, he did
the same regarding the Edward Hooper’s book, The River,
which he alleged was historically inaccurate, potentially
damaging to the public’s trust in western medicine,
and harmful to his colleagues “efforts to make AIDS
vaccines for use in Africa.”2
When
this author personally contacted Dr . Moore in an effort to
begin scientific discourse following his Canadian press interview,
Moore refused any formal discussion. Responding later to prodding,
he wrote me from the Aaron Diamond AIDS Research Center saying,
“I explicity denied you an interview when you requested
one. . . . I said to you that I had ‘no interest’
in your . . . grotesque theories . . . For the record, I know
what your views are, and I reject them. Indeed, I dismiss
them as uninteresting, incorrect and downright stupid.”
In the Vancouver Sun, Moore was further quoted as saying,
“HIV is transmitted from monkeys to humans. I don’t
think there’s any doubt about that. It’s hard
scientific reality.” In fact, according to scientific
consensus, the defining zoonosis for the origin of HIV occurred
between chimpanzees and humans, not monkeys.2
It
should be noted that Dr. Moore’s institutional benefactors
include the Rockefeller family which, along with the Rockefeller
Foundation and its institutional affiliate—the Sloan-Kettering
Memorial Cancer Center in New York—has heavily invested
in
viral
cancer research, vaccine developments, propaganda programs,
population control efforts, and the Merck pharmaceutical company
in particular. Thus, Moore’s bias is strongly suggested.2,13,14
Worse
yet, history shows that soon after Dr. Gallo’s alleged
“discovery” of the AIDS virus in 1984, Dr. Moore
co-directed the only official effort to examine Merck’s
HB vaccine for “fear of possible AIDS transmission.”23 His
principle co-investigator was Dr. B.J. Poiesz at the State
University of New York. Dr. Poiesz, their paper noted, had
worked closely with Dr. Gallo in isolating the “type-C”
cancer virus associated with lymphomas during the mid to late-1970s. Their
group of researchers included “anonymous CDC authors”
who, for unspecified reasons, omitted the centrally important
New York City and African HB vaccine recipients from their
analysis. Adding insult to this injury, the team’s conclusions
were entirely inconsistent with earlier epidemiological
determinations and serological measures.13
Reinforcing
the observance of such political bias and tainted science
in this field of inquiry is the conclusion reached by several
featured speakers at the Royal Society’s meeting in
London. They addressed the “burden of proof” required
of iatrogenic versus natural AIDS origin theorists. 10,
19, 20 These
experts protested the unfair unscientific advantage that has
been historically given to outspoken natural evolution theorists,
such as Dr. Moore, who have been curiously exempt from having
to substantiate their obviously flawed claims and hypotheses.
Ironically, despite this, their unproven misguided theories
remain widely accepted as supposed fact.10,
19,20
The
only remedy such deception is updated knowledge regarding
the advanced genetic analyses that have seriously undermined
arguments for isolated viral leaps that cannot adequately
explain the source of AIDS and the “sunburst phylogeny”
of HIV’s earliest African strains.10
In the wake of the Royal Society’s symposium, theories
that now appear tenuous, if not ludicrous, include isolated
parenteral (i.e., skin piercing) injuries (e.g., the “cut
hunter theory”), nutritional exposures, population movements,
and climatic variations that are alleged to have led to isolated
zoonotic events followed years later, evolutionarily, by the
spreading plague. Alternatively, many participants at the
conference concluded that the transfer of SIV to human beings
was probably connected with unprecedented medical activity
in Africa in the 20th century.”21
Bionetics
Evidence to be Reconciled
What
continues inadequately reported in the scientific literature,
perhaps because researchers remain unaware, or because most
investigators would certainly feel threatened by such disconcerting
revelations, was that the precise scenario advanced by Myers
et al.,10 to best account for the
sunburst phylogeny and “punctuated origin” event
was repeatedly engineered and studied during the Litton Bionetics
(LB) administered SVCP, at precisely the time (1969-1974)
required to produce the “Big Bang,” as Myers originally
called it. At this same time, LB’s study of HB viral
co-infections with viruses currently linked to HIV-related
immune suppression and AIDS symptomatology was ongoing, as
you will read below. This information comes directly from
their contract titled, “Investigations of Viral Carcinogenesis
in Primates” (NIH Grant Number 71-2025 beginning February
12, 1962). This team, officiated by NCI “Project
Officer” Dr. Robert Gallo, the subsequent discoverer
of HTLV-1,2 (leukemia viruses) and
HIV-1 (the AIDS virus) almost 15 years later, stated:
“During
the past year [1970] macaques were inoculated at birth or
in utero with the Mason-Pfizer monkey mammary virus, Epstein-Barr
virus (EBV), Herpesvirus saimiri, and Marek’s disease
virus. EB virus was given with immunostimulation and immunosuppression
(ALS, prednisone, imuran). Australian antigen [HB virus] was
given to newborn African green monkeys.”
Might
this quoted knowledge have impacted Dr. Gallo’s earliest
declaration that the origin of HIV-1 came from “African
greens” (i.e., SIVagm), and/or Dr. Hilleman’s
confession that he brought the AIDS virus into North America
in African greens?
Furthermore,
it is well known that HIV-2 sources from macaque monkeys from
this same time period.8 Might this
specific multiply-infected simian colony be the source of
the original SIV to HIV zoonosis? There is much evidence to
suggest this, and it is certainly worthy of an official inquiry.
It
is also curious that EBV was of major interest to the LB team
of researchers.
It
is also well known that EBV is a potent co-carcinogen with
HIV-1 and deadly co-factor in the development of AIDS.
This
1971 report by Landon, Ting and Gallo et al., referenced the
use of “colony-born” primates observed for seroconversion
to “EB positive” immune suppressive status predisposing
the animals for retroviral infections and cancers. To summarize
this work, conducted almost a decade before Dr. Gallo “discovered”
the first leukemia retrovirus (HTLV-I), and later HIV-1, his
Bionetics coworkers disclosed that their:
“![Beer [B]](/cs/emoticons/emotion-22.gif) reeding
and holding colonies were surveyed for antibody to EBV. All
breeders were positive and their offspring contain maternal
antibody for several months. . . . [Moreover,] An RNA-dependent
DNA polymerase, [the primary AIDS-linked enzyme] similar to
that associated with RNA tumor viruses, was detected in human
leukemic cells but not in normal cells stimulated by phytohemagglutinin.
The enzyme was isolated, purified and concentrated 200-fold,
making possible its further characterization and study in
relation to the leukemic process in man.”33
This
document, and statement alone, considering its date, should
be adequate impetus for an independent investigation into
the SVCP with regard to the origin of AIDS.
Reflecting
on the specific scenario advanced by Myers and co-workers
regarding the phylogenetic, recombinant, and immunosuppressive
correlates and antecedents of the “starburst”
that reflects at least ten simultaneous HIV/AIDS African outbreaks,
the Bionetics investigators stated the significance and “proposed
course” of their vaccine research involving chimpanzees. They
wrote:
“Significance
to Biomedical Research and to the [Special Virus Cancer] Program
of the [National Cancer] Institute: Inasmuch as tests for
the biological activity of candidate human [cancer] viruses
will not be tested in the human species, it is imperative
that another system be developed for these determinations
and, subsequently for the evaluation of vaccines or other
measures of control. The close phylogenetic relationship of
the lower primates [i.e., chimpanzees] to man justifies utilization
of these animals for these purposes. Further study of altered
transfer RNA and polymerase enzymes would determine their
significance in neoplastic change and provide a basis for
selection of therapeutic agents.
“Proposed
Course: Continuation with increased emphasis on monitoring
and intensive care of inoculated animals to determine if active
infection occurs, effects of infection, and degree of immunosuppression
when used. Further studies of human neoplasms at a molecular
level will continue.”33
Inasmuch
as humans were not being directly infected with “candidate
viruses” during this program according to the contract
summary, live viral vaccines derived from retroviruses similar
to the HIVs were being prepared and tested in primate populations
that apparently included humans as well as chimpanzees. This
at the precise time that the Australian antigen—the
HB highly infectious and easily transmissible cancer virus—and
related HB vaccines were being injected into both chimpanzees
and humans in New York and Sub-Saharan Africa by LB collaborators.33
At
the XI International Conference on AIDS in 1996, when questioned
regarding his involvement in these Bionetics studies, Dr.
Gallo angrily replied to this author, “Quite frankly,
I don’t know what the hell you’re talking about.”13
If the HB vaccine theory might be the focus of a reputable
independent inquiry, such as the one urged by Cribb,19
and now AI members, Dr. Gallo might be obliged to formally
discuss his contract with Bionetics wherein the “Australian
antigen was given to newborn African green monkeys”
in the context of testing “a swarm of [candidate viral
and retroviral] variants.” If he still contends this
HB vaccine/origin of AIDS theory has no merit, as he argued
forcefully at that time, then perhaps he would be willing
to publish an alternative account reflecting more recent scientific
revelations.
Huebner
et al, referred to in Bionetics’s SVCP contract (NIH-71-2025),
might also be persuaded to divulge valuable insights regarding
this HB vaccine/origin of AIDS thesis.34
At that time, 1969, Dr. Robert Huebner was also a leader in
this field on the esteemed National Academy of Sciences–National
Research Council (NAS–NRC), that is, at precisely the
time the Congressional Appropriations Committee heard testimony
concerning the technical expertise available through the NAS–NRC
for the U.S. Army’s development of AIDS-like viruses.
At that time these viruses were referred to by military personnel
in the Congressional Record as “synthetic biological
agents.” However, the scientific community referred
to them as “type-C” RNA tumor viruses. Huebner
was exquisitely aware of these developments and various retroviral
species that were routinely being generated using crude early
methods of recombination in SVCP labs. Again, these viruses
were descriptively and functionally identical to HIV-1.2,3,13,14 According
to the Bionetics contract summary report from 1972, Dr. Huebner’s
group isolated and tested a cat/human hybrid oncornavirus,
RD-114, from a human sarcoma by 1971. Sarcomas, associated
with leukemias and lymphomas in AIDS patients were, at that
time, unheard of in gay men. Later, in 1981, HB virus and
vaccine expert, Dr. Don Francis, relayed his opinion as to
the source of the first GRID (AIDS) cases in New York, “It’s
a combination of feline leukemia and hepatitis B,” he
told his mentor Max Essex at Harvard.35
The
following SVCP contract excerpt34 discusses the testing of
effective treatments for HIV/AIDS-like infections at that
early date:
“The
effects of 11 rifamycin derivaties on viral reverse transcriptase
and on DNA polymerases from human normal and leukemic blood
lymphocytes were evaluated. Compound 143-483, 3-formyl rifamycin
SV: octyl oxime showed the greatest potency and inhibited
all DNA polymerases from both viral and cellular origins.”
Might
this be a cure for HIV/AIDS? Unless further investigations
into this matter are conducted, we may never know.
Reflecting
on these revelations in-so-far-as the myriad viral recombinants
potentially contaminating LB’s labs and caged animals,
and the determinations of Myers et al,10
a most appropriate question is, “Why only ten forms
of HIV/AIDS broke out during the early1970s?” It would
seem likely that many of the SIVs originated from these investigations
as well as other pandemics such as herpes that exploded during
the mid to late 1970s along with immune suppressive disorders
associated with EBV infections and related cancers. Obviously,
it would be helpful to investigate the possibility of other
plagues that may have derived from vaccine contaminations
and transmissions during the SVCP.
Many
researchers, in fact, issued forewarnings about the grave
risks posed by recombinant cancer virology.13
Others cited similar risks from public health’s “sacred
cow” vaccinations.31 It is
sobering to reflect on this knowledge in the wake of the Royal
Society’s publications and official evaluations.19
Considering
The Genocidal Theory of AIDS
The
1998 report of Zhu et al.9 was well
timed to help promote co-author Edward Hooper’s book,
The River, which substantially reinforced a previously advanced
OPV theory of AIDS’s origin,12
and gave only superficial consideration to possible hepatitis
B vaccine contaminations as the zoonotic vector for transferring/transforming
SIVcpz into the human AIDS virus by 1976.4
Hooper referenced Emerging Viruses: AIDS & Ebola—Nature,
Accident or Intentional? among the texts that explore the
genocidal theory of AIDS which he credited for his background
on the hepatitis B theory.13 He
cautioned against blanket acceptance of the intentional theory
of HIV/AIDS, which is consistent with the proposed AI investigation
of the SVCP, but he did not rule out the possibility that
HIV was released intentionally.4
As
Weiss stated, theories involving the CIA in the origin of
AIDS have gained wide acceptance.6
Investigations by Horowitz et al.2,3,13
focused on the CIA and the 1969 appropriations hearings in
which the NAS–NRC was credited as the source of technical
expertise for the U.S. Army’s development of AIDS-like
viruses. At that time, biological weapons were of great interest
to Nelson Rockefeller’s protégé, and Nixon
administration National Seurity Advisor (NSA), Dr. Henry Kissinger.
According to his biographer, and two previous CIA directors—William
Colby and Richard Helms—Kissinger oversaw the CIA’s
top secret biological weapons program called MK:NAOMI. Soon
after becoming NSA, he ordered a review of such weapons capabilities.13-15
Furthermore,
in the early 1970s, in keeping with U.S. Government and global
industrialists’ initiatives reflecting Rockefeller-directed
Population Council urgings for Third World depopulation, Kissinger
requested and received National Special Security Memorandum
200 articulating the urgency of dramatically reducing African
populations.16 At that time Kissinger
and associates were leading advisors to the Merck pharmaceutical
company whose president, George W. Merck, was America’s
biological weapons industry director, as he had been since
World War II.17
According
to Hooper, the genocidal hypothesis of HIV/AIDS should be
“taken with a grain of salt.”4 It
is clear, however, that compelling evidence exits, albeit
circumstantial, that U.S. Government officials, including
Henry Kissinger, may have had something to do with the initial
HIV/AIDS outbreak. At the precise time corresponding to the
earliest transmissions of HIV/AIDS, Kissinger directed a national
security cryptocracy that included corporate affiliates at
the biological weapons contractor /vaccine maker Merck, as
well as the traditional weapons contractor Litton Industries.
Litton’s president, Roy Ash, also served in the Nixon
administration overseeing American industry. Litton’s
medical subsidiary, Bionetics, as detailed above, largely
directed the NCI’s SVCP, administered America’s
premier biological weapons testing center at Fort Detrick,
Maryland, and supplied the chimpanzees, monkeys, monkey viruses,
primate cell lines, and other resources for cancer research,
biological weapons development, and
vaccine manufacture.
Thus,
Kissinger certainly maintained the means, through his official
channels at Merck, Litton Bionetics, and the CIA, as well
as the motive, to deploy AIDS-like viruses by 1974 in Merck’s
HB vaccine. What is unconscionable to most people, Kissinger,
a staunch advocate of African depopulation, would have considered
it convenient that the emergence of HIV/AIDS in sub-Saharan
Africa coincided synchronously with the massive depopulation
policy institutionalized with primary funding from the Rockefeller
Foundation and the Merck Fund.2,3,13,14
Most
recently, Kissinger’s direction of foreign genocidal
operations has been heralded by even mainstream periodicals.36
In light of these revelations, it is stunning that Kissinger
wrote his own genocide indemnification policy on behalf of
the United States Government in Foreign Affairs published
by the Council on Foreign Relations in 2001.37
The
Challenge Before Us
“There
is a crisis of public faith in science and scientists,”
stated Dr. Julian Cribb, referring to the contentious manner
in which origin of HIV/AIDS research and debate has been conducted
thus far. “What I have described is . . . a systematic
endeavour to suppress public discussion and scientific inquiry
into this important [vaccine] hypothesis and to discredit
its proponents over more than 12 years.”
He
summarized before the esteemed Royal Society gathering. “Unless
scientists are prepared to go into this issue objectively
and transparently, it will damage the standing of science
in the eyes of the community.” 19
Determining
the origin of HIV/AIDS is vital for the following reasons
according to Cribb: 1) to prevent similar calamities in the
future; 2) to discover remedial
methods and materials that might evolve from such knowledge;
3) to improve safety standards in
viral laboratories and vaccine production facilities based
on the knowledge of the pandemic’s origin; and 4)
to restore faith and trust in this area of science and medicine.
19
Furthermore,
Cribb argued, “If AIDS is iatrogenic, through an honest
mistake, science may be forgiven. But if it seeks to bury
the idea, first, it will fail and second, it will destroy
public trust.” To the extent that the HB vaccine theory
of AIDS is officially neglected, as Hamilton foretold: “This
hypothesis is certainly not going to go away.”19
But
if the HB vaccine theory on the origin of AIDS, as current
science overwhelmingly supports and the “process of
elimination” has virtually proven, is ultimately accepted,
then Cribb’s forgivable “honest mistake”
conjecture might need to be reexamined against more unnerving
possibilities.
At
the time of this writing, the U.S. Homeland Security Act passed
the Senate virtually unanimously. Mysteriously incorporated
in its text was a vaccine injury indemnity clause that freed
drug companies from liabilities associated with specific vaccine
ingredients, such as HIV precursors in the HB vaccines. With
this gross violation of U.S. constitutional, civil, and human
rights, hundreds of thousands of Americans have been forced
to care, without compensation, for vaccine injured family
members. If the U.S. Government is able to get away with this
most blatant breach of public faith, what is it capable of
doing covertly? Clearly, this current vaccine policy
is a form of institutionalized genocide—defined as “the
mass enslaving (pharmaceutically and otherwise) and killing
of people for economics, politics, and/or ideology?”
So
long as the above scientific facts and AIDS issues remain
unaddressed by medicine’s mainstream, the implications
are that AIDS science and vaccination policies, and likely
all of science, has evolved in a vacuum devoid of ethics to
serve political, economic, and/or ideological motives. Thus,
by strict definition, genocide and iatrogenesis have much.
So much so that regardless of whether HIV/AIDS originated
by accident or intentionally, with this data, there is sufficient
justification to coin a new most appropriate term—“iatrogenocide.”
Further
research to test this hypothesis should include: retrospective
epidemiological studies of homosexual populations in New York
reported to have received the earliest HB vaccines; serological
studies of any stored blood and/or serum from these early
HB vaccine study subjects; likewise for the chimpanzees used
in the preliminary trials and/or vaccine manufacture; and
genetic analyses of viral components in samples of the vaccine
lots used during these earliest HB vaccine trials (if still
available).
About
the Author
Leonard
G. Horowitz, D.M.D., M.A., M.P.H., is an internationally known
authority in the overlapping fields of public health, behavioral
science, emerging diseases, and bioterrorism. He received
his doctorate in medical dentistry from Tufts University School
of Dental Medicine in 1977, was awarded a post-doctoral fellowship
in behavioral science at the University of Rochester, earned
a Master of Public Health degree from Harvard University,
and another Master of Arts degree in health education from
Beacon College, all before joining the research faculty at
Harvard. Dr. Horowitz is best known for his national bestselling
book, Emerging Viruses: AIDS & Ebola—Nature,
Accident or Intentional? (Tetrahedron Press, 1998; 1-888-508-4787)
which
recently resulted in the United Stated General Accounting
Office investigating the man-made origin of AIDS theory. (See:
http://www.healingcelebrations.com/gao.htm) Dr. Horowitz’s
brilliant work in the field of vaccination risk awareness
has prompted at least three Third World nations to change
their vaccination policies. His recent stunning testimony
before the United States Congress’ Government Reform
Committee, literally brought the hearing to a halt. (See:
http://www.healingcelebrations.com)
Dr. Horowitz questioned government health officials regarding
a Centers for Disease Control and Prevention (CDC) secreted
report showing a definitive link between the mercury ingredient
(i.e., thimerosal), common to most vaccinations, and the skyrocketing
rates of autism and behavioral disorders affecting our children
and the future our nation.
Incredibly,
Dr. Horowitz alerted the FBI, in writing and in person, one
week before the first anthrax mailing was announced in the
press, that a “major anthrax fright” was in the
process of unfolding that demanded the FBI’s urgent
attention. Needless to say they did not heed Dr. Horowitz’s
prophetic warning.
Moreover,
three months before the September 11 attacks on the World
Trade Center and Pentagon, Dr. Horowitz released his thirteenth
book, prophetically titled Death in the Air: Globalism, Terrorism
and Toxic Warfare. The book focuses on the West Nile Virus
as an act of bioterroism, and considers what and who is really
behind this and other recent outbreaks. Dr. Horowitz argues
that his disclosures expose the roots of global terrorism,
along with the individuals and organizations at the heart
of what he calls “the petrochemical–pharmaceutical
cartel.” He believes this “multi-national corporate
beast” is in the process of committing global genocide,
profiting from engineered frights, and at the same time, most
efficiently culling targeted populations considered excessive.
Very
recently, you may have heard that Senator Patrick Leahy (D-VT),
Chairman of the Senate Judiciary Committee, called for an
investigation into the links between the recent West Nile
Virus outbreaks and bioterrrorism. Dr. Horowitz is the principle
pioneer and investigator of this theory.
Dr.
Horowitz’s contact information, books, audiotapes, and
video programs are available through www.tetrahedron.org,
or by calling 1-888-508-4787.
References
(1)
Heinrich J. Origin of AIDS Virus. Washington, DC: U.S. General
Accounting Office, GAO-02-809R; available from http://
www.gao.gov/main.html. See also:Tetrahedron Publishing
Group press release, “U.S. GAO Commits Scientific
Fraud In AIDS Inquiry: Congressional Investigators Conceal
and Lie Says Expert,” available from healingcelebrations.com.
(2)
Horowitz LG. Polio, hepatitis B and AIDS: an integrative
theory on a possible vaccine induced pandemic. Med Hypoth
2001;56(5):677-686.
(3)
Horowitz LG, Strecker R, Cantwell SR, Vid, D, and Grossman
G. The Mysterious Origin of HIV: Reviewing the Natural,
Iatrogenic and Genocidal Theories of AIDS. XI International
Conference on AIDS, July 10, 1996, Vancouver, BC. Canada.
See full text of abstract and presented paper Here
(4)
Hooper E. The River. Boston: Little, Brown and Company,
1999.
(5)
Hamilton, WD., quoted by Julian Cribb in “The origin
of acquired immune deficiency syndrome: can science afford
to ignore it?” Phil. Trans. R. Soc. Lond. B 2001;356:935-938.
(6)
Weiss, RA, Natural and iatrogenic factors in human immunodeficiency
virus transmission. Phil. Trans. R. Roc. Lond. B 2001;356,947-953.
(7)
Yusim K, Peeters M. Pybus OG and Korber B, et al. Using
human immunodeficiency virus type 1 sequences to infer historical
features of the acquired immune deficiency syndrome epidemic
and human immunodeficiency virus evolution. Phil. Trans.
R. Roc. Lond. B 2001;356,855-866.
(8)
Sharp PM, Bailes E, Chaudhuri RR and Hahn BH, et al. The
origins of acquired immune deficiency syndrome viruses:
where and when? Phil. Trans. R. Roc. Lond. B 2001;356,867-876.
(9)
Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM and Ho
DD. An African HIV-1 sequence from 1959 and implications
for the origin of the epidemic. Nature 1998;391(Feb. 5):594-597.
(10)
Burr T, Hyman JM and Myers G. The origin of acquired immune
deficiency syndrome: Darwinian or Lamarchkian? Phil. Trans.
R. Soc. Lond. B (2001) 356:877-887; For early research regarding
the “Big Bang” theory of HIV, see also: Myers
G, Macinnnes K and Myers L. “Phogenetic moments in
the AIDS epidemic.” Chapter 12 in S.S. Morse, ed.,
Emerging Viruses (Oxford, Eng.: Oxford University Press,
1993).
(11)
Marx PA, Alcabes PG and Drucker E.11 “Serial human
passage of simian immunodeficiency virus by unsterile injections
and the emergence of epidemic human immunodeficiency virus
in Africa” Phil. Trans. R. Soc. Lond. B (2001) 356:911-920.
(12)
Elswood B and Stricker R. Polio vaccine and the origin of
AIDS. Med Hypoth 1994;42,347-354.
(13)
Horowitz LG and Martin WJ. Emerging Viruses: AIDS &
Ebola—Nature, Accident or Intentional? Sandpoint,
ID: Tetrahedron Publishing Group, 1998. Note: the Hilleman
revelations concerning leukemia virus tainted yellow fever
vaccines discussed on page 485 derive from a sequestered
recorded interview conducted in 1986 by Edward
Shorter for a Merck funded documentary, “The Health
Century.”
(14)
Horowitz LG. Death in the Air: Globalism, Terrorism
and Toxic Warfare. Sandpoint, ID. Tetrahedron Publishing
Group, 2001.
(15)
Isaacson W. Kissinger. New York: Simon & Schuster, 1992,
p. 205.
(16)
National Security Agency. National Special Security Memorandum
200: Implications of Worldwide Population Growth for U.S.
Security and Overseas Interests. The White House: December
10, 1974 (Declassified July 3, 1989.).
(17)
Covert NM. Cutting Edge: A history of Fort Detrick, Maryland
1943-1993. Fort Detrick , Maryland: U.S. Army Garrison,
Public Affairs Office, 1993, pp. 17, 20, 39.
(18)
Plotkin SA. Untruths and consequences: the false hypothesis
linking CHAT type 1 polio vaccination to the origin of human
immunodeficiency virus. Philos Trans R Soc Lond B Biol.
Sci. 2001 Jun 29:356(1410):815-823.
(19)
Cribb J. The origin of acquired immune deficiency syndrome:
can science afford to ignore it? Phil. Trans. R. Soc. Lond.
B 2001;356:935-938.
(20)
Martin B. The burden of proof and the origin of acquired
immune deficiency syndrome. Phil. Trans. R. Soc. Lond. B
2001;356:939-938.
(21)
Bliss M. Origin of AIDS (letter). The Lancet 2001;357 (January
6):73-74.
(22)
Gao F, Bailes E, Shaw GM, Sharp PM and Hahn BH et al. Origin
of HIV-1 in the chimpanzee Pan troglodytes troglodytes.
Nature 1999 (Feb. 4);397:436-440. See also: Horowitz LG.
Response to Zhu et al. 1959 Origin of AIDS. Unpublished
letter to the editor of Nature. Available for review Here
; See also: Horowitz L. Analysis of Gao F and Bailes E study.
Unpublished report available for review Here
(23)
Poiesz B, Tomar R, Lehr B and Moore J. (along with anonymous
CDC authors). Hepatitis B vaccine: Evidence confirming lack
of AIDS transmission. MMWR 1984;33;49:685-687.
(24)
Marriott SJ, Lee TH, Slagle B and Butel JS. Activation of
the HTLV-1 long terminal repeat by the hepatitis B virus
X protein. Virology 1996, 224;1:206-213.
(25)
Higginson J and Muir CS. Epidemiologic program of the International
Agency for Research in Cancer (IARC) In: The National Cancer
Program and International Cancer Research, National Cancer
Institute Monograph 1974 (40:65).
(26)
Jamison E and Hobbs F. World Population Profile: 1994, With
a Special Chapter Focusing on HIV/AIDS (WP/94) by Peter
O. Way and Karen A. Stanecki). Washington, DC: U.S. Government
Printing Office by the U.S. Department of Commerce, Washington,
DC, 1994.
(27)
Goodfield J. Quest for the Killers. Basel; Stuttgart: Birkhauser,
1985, p. 94.
(28)
Kanki PJ, Barin S, Essex M. et al. New human T-lymphotropic
retrovirus (HTLV-IV) related to simian T-lymphotropicvirus
Type III (STLV-IIIagm). Science 1986;232:238-43.
(29)
Schultz TF. Origin of AIDS (letter). The Lancet 1992;339:867.
(30)
Krugman S. Viral hepatitis type B: Prospects for active
immunization. In: International Symposium on Viral Hepatitis,
Milan, Dec. 1974. Develop. biol. Standard. Vol. 30, Munich:
S. Karger Basel, 1975, pp. VI; 363-367; relevant general
discussion can be found on pp.375-379; See also: Krugman
S, Giles JP, Hammond J. Hepatitis virus: effect of health
on the infectivity and antigenicity of the MS-1 and MS-2
strains. J Infectious Disease. 1970;122:432-6; Krugman S,
Giles JP, Hammond J. Viral hepatitis, type B (MS-2 strain):
Studies on active immunization. JAMA 1971;217:41-5; Krugman
S, Giles JP. Viral hepatitis, type B (MS-2 strain); further
observations on natural history and prevention. New England
Journal of Medicine 1973;288:755-60; and Krugman S, Overby
LR, Mushahwar IK, Ling C-M, Forsner GG and Deinhardt F.
Viral hepatitis, type B: Studies on natural history and
prevention reexamined. New England Journal of Medicine 1979;200:101-6.
(31)
Beale J. Origin of AIDS (letter). The Lancet 2001;357 (January
6):73.
(32)
Purcell RH. Current understanding of hepatitis B virus infection
and its implications for immunoprophylaxis. In: Antiviral
Mechanisms: Perspectives in Virology IX. The Gustav Stern
Symposium. New York: Academic Press, 1975, pp. 49-76.
(33)
NCI staff. The Special Virus Cancer Program: Progress Report
#8 [and #9]. Office of the Associate Scientific Director
for Viral Oncology (OASDVO). J. B. Moloney, Ed., Washington,
D. C.: U. S. Government Printing Office, 1971 [and 1972].
Note: This is a very hard publication to find. Few library
data bases have it listed, including the NCI Library at
Fort Detrick. It is available through the Davis Library,
The University of North Carolina, Chapel Hill, Government
Documents Department Depository, Reference # HE 20.3152:V81.
The Litton “support services” contracts that
included primate supplies are found on pp. 187-88 and 326-327
of the reports. Litton’s list of mutant viruses, including
retroviruses, and other experimental infectious agents including
AuAg is found on pp. 279-280 and 284 of Project Report #8,
of 1971; for additional documentation on hepatitis and herpes
experimentation in Uganda before 1971 see: Higginson J and
Muir CS. Epidemiologic program of the International Agency
for Research on Cancer (IARC). In: The National Cancer Program
and International Cancer Research, National Cancer
Institute Monograph, 1974; 40:65.
(34)
Rabin H, Kinard R. Gruber J and Pearson G. Bionetics Research
Laboratories, Inc. (NIH 71-2025) Investigations of viral
carcinogenesis in primates. Here reference is made to “Drs.
McAllister, Gardiner, and Huebner” having “isolated”
the cat-human hybrid oncornavirus, RD-114, “from a
human sarcoma” as early as 1971. See reprinted contract
summary in Horowitz, Op cit. 1998, p. 429.
(35)
Shilts R. The Band Played On. New York: Penguin Books, 1987,
p. 107.
(36)
Hitchens C. The Case Against Henry Kissinger. Harper’s
Magazine, February and March, 2001.
(37)
Kissinger HA. The pitfalls of universal jurisdiction. Foreign
Affairs. July/August 2001. Preview available from through
http://www.foreignaffaris.org.
|
| |
|
|
|
|
|
Report
|
|
|
|
|
28/06/2009, 7:08 AM
|
GreenBlue
Joined on 01/06/2008
Posts 1,598
|
|
|
|
|
But others say it was nothing to do with Bayer; but from Granjas Carroll (who muck around with GM frankenstein pigs), which is located near La Gloria/Perote Veracruz state where it all kicked off. Has Bayer a facility in veracruz state that specifically produces Tamiflu? "Local health authorities in La Gloria and Perote have determined that this “strange” flu-like disease or “new strain of the flu” was spread to the local towns by flies that feed on pig ***. In the town of La Gloria, 60 percent of the 3,000 inhabitants have been infected."
AUSTIN, Texas -- The recent swine flu outbreak taking place in Mexico may have originated at a US-owned pig-breeding farm by the name of Granjas Carroll (aka Carroll Farms), which is owned, in part by the Smithfield Food Company.
Smithfield also promotes the consumption of genetically-altered foods, and even owns certain genetic lines of pork breeding. On April 12 of 2009, before the swine flu outbreak was covered by mainstream media outlets, the Mexican newspaper La Jornada broke a story on how Carroll Farms was polluting the drinking water near the towns of La Gloria and Perote, in Veracruz.
According to La Jornada, Carroll Farms maintains a strong political influence in municipal governments in the area. Recently, group of environmental protesters that blocked a highway near the Carroll Farms facilities was arrested. Among them were Guadalupe Serrano Gaspar, a 66-year-old man who said was arrested by undercover police officers. Local residents from 20 towns nearby in Veracruz and the bordering state of Puebla also oppose what they consider deplorable environmental practices by Carroll Farms. The complaints from local residents range from reports of large quantities of pig excrement in the waterways to the smell of chemicals and *** in several towns.
Veratect, which is company that tracks epidemic outbreaks, has posted a timeline of events that also indicates that the Mexican swine flu outbreak may have started in Veracruz, Mexico near the Carroll Farms facilities. According to the Veratect timeline, more than 400 local residents at La Gloria, Veracruz and other nearby towns reported having strong flu-like symptoms days before the outbreak was reported by the media. Local health authorities in La Gloria and Perote have determined that this “strange” flu-like disease or “new strain of the flu” was spread to the local towns by flies that feed on pig ***. In the town of La Gloria, 60 percent of the 3,000 inhabitants have been infected.
The newspaper La Jornada also reported that local health officials and residents found “clouds of flies” feeding on organic pig waste, carcasses and ***. Reportedly, Carroll Farms has been dumping organic pig waste out in the open, leaving it exposed for the flies to feed.
The swine flu has now been spreading to major cities in Mexico, the US and Canada. In Mexico, over 900 people are dead. Mexico City has begun to close down schools, churches, and libraries. The Mexican government is planning to vaccinate 500,000 people, although it is widely known that there is no vaccine for this latest strain of swine flu because it has not yet been produced.
http://www.reddirtreport.com/news.php?id=10649
|
|
|
|
|
Report
|
|
|
|
|
02/07/2009, 11:37 PM
|
Hide the decline
Joined on 12/03/2008
Posts 1,356
|
|
|
|
| ironsmad wrote: | For this virus to have random natural occurrence, jumping back and forth ,bird,pig,human...Yet no evidence of pigs in Mexico of having swine flu, no mass culling of pigs in Mexico or the US. Only Egypt have done any mass culling. Adrian Gibbs is at the top of his profession, has nothing to gain from suggesting Bio/Lab escape. The vast companies like Bayer will be the one's minted up. It has to myself and many others, the hall marks of classic EU/USA/UN sting. How far these global elite want to run with their enslavement ,control of world population is any one's guess.
|
|
|
|
|
|
|
|
|
|
|
Updated 11/07/02
Please use the menu below to jump to a topic:
|
AIDS & HIV Articles
-----------------------------------------------------
THE GENESIS &
CHRONOLOGY OF THE DEVELOPMENT OF HIV/AIDS :
New genocidal
AIDS vaccine experiments
Side Effects
of AIDS Drugs and Lower Prices for Africa
Study: AIDS Devastating
Africa
Early Hepatitis
B Vaccines and the “Man-Made Origin of HIV/AIDS:
U.S. GAO Investigated
the Wrong AIDS Origin Theory
Polio, Hepatitis
B and AIDS
The US Shadow Government
Perspectives
on a Possible Vaccine Induced Pandemic
AIDS: Genocial Germ
for a New World Order?
False Hope or Guilty
Conscious?
<< Return
to AIDS & HIV Press Releases
|
| FEATURED
ARTICLE
Early
Hepatitis B Vaccines and the “Man-Made” Origin
of HIV/AIDS
by
Leonard G. Horowitz, D.M.D., M.A., M.P.H.
This
article regards a matter of global urgency transcending better
known AIDS threats. It describes a universal challenge posed
by ever increasing numbers of plagues predicted to depopulate
at least half of the world’s current human inhabitants
within two generations. This documented science virtually
proves, through the process of elimination and a review of
the most updated evidence, the origin of HIV/AIDS as an iatrogenic
(i.e., man-made) outcome of specific vaccination experiments.
Considered
reflection on this AIDS science, along with the sociopolitical
correlates and antecedents of this current catastrophe, reveals
the likelihood that myriad other immune
dysfunctions, autoimmune diseases, and cancers, including
leukemias, lymphomas, sarcomas, and other ailments linked
to viral infections, have resulted from previously engineered
microbes that have by accident or intent found their way from
cancer virus laboratories into humanity’s bloodstream
by way of the most trusted public health preventative—vaccinations.
If
what you are about to read is true, and each point is precisely
stated and meticulously documented, beyond extensive depopulation,
humanity’s very survival may hinge on this recognition,
its implications, and our considered response. Especially
relevant, when reflecting on the following facts, is the wisdom
addressed by the late World Health Organization (WHO) AIDS
czar, Dr. Jonathan Mann, whose life ended tragically on Flight
111 enroute to a European AIDS conference. “More than
a medical scientific problem,” Dr. Mann said, “AIDS
is a sociopolitical imposition.”
Background
AIDS
is undoubtedly “man-made.” We can now assert this
“very apparent iatrogenic origin,” versus the
“theoretic iatrogenic origin” of HIV/AIDS because
of the rapidly increasing, now substantial, scientific support
for this conclusion. Currently, international scientific consensus
among leading investigators in this field, many of whose works
and words are excerpted below, holds that HIV/AIDS originated
from one or more extraordinary man-made, not natural, events
dating back to the early to mid-1970s. Especially implicated
in initiating the AIDS pandemic, according to many scientists
and scholars, was the hepatitis B vaccine as detailed in the
following pages.
This
may come as a surprise, or even quite a shock, to most people
since the mainstream media and most respected medical journals
have yet to herald the following knowledge. As a result most
“authorities” still issue false and misleading
claims such as: 1) “the HB vaccine theory of HIV/AIDS
origination has been discussed, debated, and dismissed by
an overwhelming majority of the HIV/AIDS research community;”
2) “People who claim that AIDS was man-made provide
false information and hearsay;” 3) “It is sad
that public attention and resources are diverted to attend
to such unscientific dribble;” 4) “Man-made origin
of AIDS vaccine proponents do severe damage to the public
health community and vaccination efforts;” and 5) “Those
that advance man-made theories of AIDS have financial motives,”
as though there were no financial interests on the other side
of the debate.
As
a pro bono consultant contacted recently by Amnesty International
(AI) members who desired to advance a resolution for the global
organization to investigate this HB vaccine thesis, I was
appalled by the amount of resistance and politicking performed
by members of AI’s so-called “HIV/AIDS Task Force”
which sought $1 billion of relief for human rights violations
associated with HIV/AIDS from the U.S. Government. These funds,
the Task Force reported, were urgently needed to buy drug–cocktails
for persons with HIV/AIDS. Each of the five claims cited above
were issued by members of this Task Force completely ignorant
of the following science.
With
regard to the first offensive claim, as the sole author of
“Polio, hepatitis B and AIDS: an integrative theory
on a possible vaccine induced pandemic” published by
Harcourt Publishers, Ltd. of London in the esteemed international
journal of Medical Hypothesis,2
this well-focused thesis has never been “discussed,
debated,” nor “dismissed” by any consensus
in any official capacity. Although Black Americans have been
polled regarding the origin of HIV/AIDS being man-made,3
there has never been a published polling of the scientific
community in this regard, and certainly not one regarding
the HB hypothesis advanced below.
HIV/AIDS
Origin Misconceptions Versus Science
Opponents
of iatrogenic (or “man-made”) theories of AIDS
have routinely confused hearsay and sporadic media propaganda
with hard science, such as that “discussed, debated”
and not “dismissed” recently at the Royal Society
of London’s inquiry into the origin of this pandemic.
They exclusively focused on the theory that contaminated polio
vaccines triggered the HIV/AIDS pandemic.4
These proceedings were published in 2001. Quotes relevant
to reasoned consideration of this unique/yet-to-be-tested
hepatitis B vaccine theory of HIV/AIDS follow. These statements
were made by featured presenters, all recognized leaders in
this multidisciplinary field discussing the polio vaccine
theory of AIDS origination. The first of these quotes is especially
relevant to
proposed investigations:
“There
should be an investigation by an international committee mostly
composed of non-medical people concerning how a rather obvious
and plausible theory [of AIDS’s origin from contaminated
vaccines] came to be scorned and restricted from publication
for so long, especially when important consequences regarding
mankind’s worst epidemic, and even more important consequences
for other possibly even worse that may be following, hang
in the balance. As a corollary it should be studied why the
hypothesis had to be promoted mainly by outsiders to science
and medicine. The ressures towards investigation (and non-investigation)
that emanate from huge drug companies and their influence
in slanting research in subtle ways should also be examined,
as should the role of journals and peer review in potentially
obstructing publications of controversial kinds.” W.D.
Hamilton,5 quoted by Julian Cribb
in “The origin of acquired immune deficiency syndrome:
can science afford to ignore it?” Phil. Trans. R. Soc.
Lond. B (2001) 356:935-938.
“Faced
with the terrible burden of AIDS, stories that HIV was introduced
into Africa from the West by an accident such as OPV [oral
polio vaccine] or intentionally by the USA Central Intelligence
Agency (CIA) have gained widespread credence. . . . Nevertheless,
because natural transmission repeatedly occurs, albeit on
rare occasions, does not mean that contamination of a vaccine
could not have been the route on another occasion. As with
other infections, e.g., hepatitis B virus,natural and iatrogenic
transmissions of retroviruses are not mutually exclusive.” Weiss,
RA6
Despite
studies that have advanced evidence suggesting an earlier
than 1970 origin of HIV/AIDS,7-9
“[t]he fact that there were ten or so synchronous but
distinguishable African epidemics is a definitive feature
of AIDS for which the natural transfer theory [e.g., the “cut
hunter transfer”] gives no convincing account. . . .
To summarize these findings regarding the relatively large
number of distinct group M subtypes: no set of likely natural
conditions . . . will adequately simulate so many as ten distinguishable
subtypes in a complex star-like configuration . . . . [T]he
onus is upon the supporters of the natural [not iatrogenic]
theory to account for the unexpectedly large number of HIV-1
subtypes. Exponential growth of the epidemic(s) is not by
itself a satisfactory explanation (Hahn et al. 2000). . .
. The likeliest source of the multiple subtypes and the synchronization
of their conspicuous diversification is a punctuated origin
[i.e., an iatrogenic event]. . . . t is not far-fetched
to imagine the ten or so clades deriving from a single animal
(perhaps immunosuppressed and possessing a swarm of variants)
[as might have been the case with chimpanzees used in the
process of vaccine manufacture] or from a few animals that
might have belonged to a single troop or might have been gang-caged
together. The number of animals required is secondary to the
extent of variation in the source at the time of the zoonotic
[i.e., transfer of the virus between species] or iatrogenic
event. The [vaccine] hypothesis makes a case for such a punctuated
origin . . .” Myers G, et al. 10
“We
conclude that SIV cannot become a zoonosis, but requires adaptive
mutations to become HIV. Some modern event must have aided
in the transition of SIV to HIV. Our research indicates that
serial passage of partially adapted SIV between humans could
produce the series of cumulative mutations sufficient for
the emergence of epidemic HIV strains . . . We conclude that
increased unsterile injecting in Africa during the period
1950-1970 provided the agent for SIV human infections to emerge
as epidemic HIV in the modern era.” Drucker E, et al.11
I
might interject at this point that this conclusion by Drucker
et al, although seriously undermining natural evolution theorists,
reflects a myopic arrogance unbecoming to their otherwise
reasonable hypothesis. Their conclusion neglects the risks
inherent in the hepatitis B vaccine manufacturing and testing
process as detailed below consistent with the analyses of
Myers et al.10 Obviously, all of
the above authoritative statements contradict “common
knowledge.” The consensus of scientists at this historic
British AIDS origin conference favored additional investigations
into possible iatrogenic sources of the HIVs.
The
1959 HIV Sequence Discovery
In
the interest of facilitating progress on this issue, much
publicity has been given to the notion that HIV was discovered
in a 1959 blood sample from Leopoldville, Zaire;9
and that scientific consensus holds 1931 as the approximate
date of HIV origination.7 These
superstitions have led to common, yet false, declarations
that HIV/AIDS originated well before the polio vaccination
era and the Special Virus Cancer Program (SVCP) that much
evidence below links to the “punctuated origin”
of AIDS.
For
the record, according to the authors of the 1959 discovery,
they never found, nor alleged to have found, HIV, or anything
like a full virus. According to these authors, even “attempts
to amplify HIV-1 fragments of >300 base pairs (bp) were
unsuccessful, . . . However, after numerous attempts, four
shorter sequences were obtained” that only represented
small portions of two of the six genes of the complete AIDS
virus.9
This
is why Gao et al, referred to the 1959 sequences as “the
oldest trace of the AIDS pandemic . . . although the precise
timing and circumstance of early events in the SIVcpz/HIV-1
zoonosis remain obscure.”22
[Editor’s note for the lay reader, “SIVcpz”
is short for “simian immunodeficiency virus from the
chimpanzee.” This is know to be the closest viral relative
to the human AIDS virus, HIV-1.]
Unfortunately,
regarding the 1959 sequences, Zhu et al., left much room for
misinterpretation if not wild speculation by stating that
given the “‘starburst phylogeny,’ HIV-1
was probably introduced into humans shortly before that time
frame, about a decade or two earlier than previously estimated.
. . .” 10 (Emphasis added.)
They speculated the zoonosis might have occurred “considerably
earlier than the late 1940s.” Obviously, this account
is irrelevant to “the extraordinary synchrony in the
1970s of ten or more distinguishable epidemics” discovered
by Myers et al. 10 Therefore, this
later group of researchers concluded that, with the exception
of the 1959 sequences suggesting viral ancestry, “Clinical,
serological and molecular retrospective studies have all failed
to produce any evidence of AIDS or HIV prior to the 1970s.”
10 (Emphasis added.) As Myers et
al., had initially advanced, the early to mid-1970s “Big
Bang” origin of HIV/AIDS is further supported by most
recent scientific evidence.10
As
if repeating false assumptions would alter historic and scientific
facts, many contemporary investigators, like those representing
AI’s HIV/AIDS Task Force, continue to imply the SIV
to HIV zoonosis occurred on or before 1959. Many natural evolution
theory evangelists continue to cite the now disproven “cut
hunter” theory to explain the origin of the pandemic.8,22 Reflecting
on Zhu et al’s position, however, they simply concluded
that the major-group viruses that dominate the global AIDS
pandemic at present shared a common ancestor in the 1940s
or the early 1950s. However, given confounding factors, including
the likelihood of viral gene recombination during the manufacture
and testing of the HB vaccine, like Korber et al.’s
speculation discussed in the next section, the 1959 “isolate”
may hold little, if any, relevance in determining the origin
of HIV/AIDS. 10
Suffice
it to say, no one has ever found a virus predating the SVCP
and the late 1970s.11 At best they
found fragments of what may have been the complete virus,
but more likely pieces of a progenitor virus they called “a
common ancestor” that dated back to “the 1940s
or the early 1950s.” These and other portions of this
“common ancestor” may have existed for centuries
if not millennia. Again, this evidence is rrelevant when considering
the 1970s “punctuated [iatrogenic] event” recently
determined to be undisputable scientific fact.
More
importantly, as Zhu and Ho et al., concluded, “the role
of large-scale vaccination campaigns, perhaps with multiple
uses of non-sterilized needles, should be carefully examined,
. . .” as contributing to the sudden emergence of HIV/AIDS
in North America and Africa simultaneously during the late
1970s.9,11
The
1931 AIDS Origin Assumption and Viral Recombination
Regarding
the 1931 estimated date of HIV’s origin advanced by
Korber et al.7 (i.e., “somewhere
between 1910 and 1950”), a critical examination of these
authors’ methods reveals problems. Largely speculative
due to their use of a confounding-factor-liable computer model,
Korber and colleagues noted their limitations. They stated
their finding(s) regarding the 1931 genetic projection, that
precludes various vaccine-induced pandemic theories, might
be wrong if viral recombination(s) had occurred. They most
certainly did in the evolutionary process of SIV to HIV according
to most cientists.10,13
Yet, despite these facts, iatrogenic theory opponents who
have secured a gross burden of proof” advantage in the
AIDS origin debate,20 repeatedly
reference this group’s work, along with the frequently
misrepresented work of Zhu, et al.9
concerning the 1959 sequence discovery.22
Again,
the “punctuated origin” of HIV/AIDS determined
by Myers et al., can only explain the nearly simultaneous
emergence of ten separate, though related, AIDS epidemics
in Africa during the early 1970s, that were well established
by 1976.10
Lending
further credence to the theory that early hepatitis B vaccine
trials provided the “punctuated event,” Korber
et al wrote of anticipated errors in their 1931 determination
using linear or recombinant evolutionary models due to “unnatural”
or iatrogenic events inciting viral recombination. They wrote
, “If there was a concentration of such recombinants
during just one period of sampling, the effect on the timing
estimate would be unpredictable.” 7
Thus,
if the “punctuated origin event” advanced by Myers
et al,10 had been the passage of
HB virus from polio vaccinated humans to chimpanzees then
back to humans, with the additional risk of recombination
from pooling hundreds of infected serum samples prior to additional
viral recombinant transfers via the HB vaccines given to human
subjects in New York City and sub-Saharan Africa, then this
might best explain the origin of HIV/AIDS and render Korber
et al’s 1931 projection inconsequential. As detailed
in the next section, this is precisely the thesis advanced
by Horowitz.2,13
In
summary, the determinations reached by Korber et al.,7
and Ho et al.,9 of possible dates
for the origin of HIV-1, 1931 and 1959 respectively, have
been adequately clarified elsewhere.10
“The authors themselves acknowledge, the super-computer-based
study cannot tell whether this hypothetical 1930 virus was
in humans or animals and so do not show when zoonosis occurred.”
7,10
Myers
et al. further qualified: “If PIV [primate immunodeficiency
virus] was in humans in the first half of the 20th century,
it may be estimated, given the assumptions of the look-back
analysis, that the ancestral HIV-1 group M virus arose at
1930 plus or minus 20 years.” Conversely, if PIV was
not in humans in the first half of the 20th century, then
the Korber et al analysis holds little, if any, value in-so-far-as
determining a date or origin of the HIVs and AIDS. 7,10
The
Earliest Hepatitis B Vaccines and The Origin of AIDS
If
early polio vaccines had not triggered the origin of HIV/AIDS
as scientific consensus now holds,6
then some other, chimpanzee-related, “iatrogenic event”
must be available to explain the staggering array of deadly
recombinants that were proven by Myers et al to have arisen
virtually simultaneously during the early to mid-1970s.10,21
In this regard, even more neglected, and perhaps more relevant
than the OPV theory of AIDS, is the hepatitis B (HB) vaccine
hypothesis.2,13,23
According
to scientific records,2 African
chimpanzees were used in the manufacture of the HB vaccines
during the early 1970s. Additional documents prove that human
HB viruses cultured in vivo in chimpanzees were returned to
humans whose infected blood serum was then pooled to develop
four different strains of experimental HB vaccine pilot tested
between 1970 and 1975 in New York City and central Africa.
This HB vaccine theory of HIV zoonosis proposes that endogenous,
or more likely exogenous, progenitor viruses were activated24
when serially transmitted from humans to chimpanzees, then
back to humans. Subsequently, pooled blood serum containing
HB surface antigen and/or live virions, a milieu ripe for
viral recombination, was used to develop the four suspected
vaccines administered to New York’s gay population and
simultaneously to sub-Saharan Africans. Besides the phylogenetic
evidence cited above, epidemiological evidence also supports
this HB vaccine theory of HIV/AIDS origination.
Figure
1 is derived from Higginson and Muir’s report on cancer
studies conducted by the International Agency for Research
in Cancer (IARC) in collaboration with the National Cancer
Institute (NCI).25 Figure 2 derives
from this data superimposed on a map of HIV-1 seroprevalence
in Africa reported by the U.S. Department of Commerce in a
publication discussing desirable depopulation associated with
HIV/AIDS.26 Additional evidence
here was supplied in the chronology of the early hepatitis
B vaccine trials compiled by Goodfield. 27
The two maps, juxaposed, show a striking correlation between
hepatitis B vaccine and liver cancer experiments conducted
in Africa during the early 1970s, and the countries in central
and southern Africa with the high est HIV-1 seroprevalence
rates by 1994. The black squares indicate areas participating
in the HB cancer virus research and vaccine trials.
It
should also be noted that Mozambique has one of the highest
rates of HIV-2, which was allegedly discovered by Essex et
al.,28 in Senegalese female prostitutes
years after the African hepatitis B vaccination pilot studies
began. Due to their state-authorized employment and high risk
for infection, Senegalese female prostitutes were required
to receive hepatitis B vaccinations for relicensure. That
Essex et al. found SIVagm, a documented vaccine contaminant,
in the blood of these human subject, is additionally compelling
evidence in support of the HB vaccine AIDS origination theory.29
In
brief, a well documented, theoretically viable, and generally
neglected evolutionary route of SIVagm to HIV-1 zoonosis sequentially
involves: 1) Polio vaccine recipients
worldwide, including gay men in New York, and Blacks in Central
Africa, were exposed to simian viruses including SV40, SFR
(Simian Foamy Retroviruses containing reverse transcriptase),
SIVagm, and perhaps others from the mid-1950s, through at
least the 1960s;2,4 2) Between 1965 and 1970, researchers
in NYC “isolated” and then inoculated the MS-2
strain of HB virus into the above cited New York and African
HB vaccine study “volunteers.”2,30
3) Human derived HB viruses, and
potentially activated retroviral sequences, were then transferred
to chimpanzees, then back again to humans in NYC and central
Africa during the development and testing of four genetically
altered subtypes of the pre-1975 experimental HB vaccine.32,33
HIV-1 progenitor contamination, recombination, and/or transmission
risks were likely increased during this process by: a) human
incubation for more than a decade of polio vaccine contaminants
and recombinants including SV40, SFR, and possibly SIVagm;
b) the pooling of infected blood serum donated by hundreds
of gay American and Black African polio vaccine recipients
who had subsequently received injections with chimpanzee cultured
strains of HB virus; c) the biohazardous laboratory conditions
and viral containment problems reported by the HB vaccine
investigators and their affiliates; and finally 5)
The four pooled serum-derived HB vaccines that were administered
to thousands of test subjects by 1975, primarily gay males
in NYC and central African Blacks. This series of events provides
the best explanation for an early to mid-1970s “punctuated
origin event” most precisely fitting the etiological
determinations of the HIV-1/AIDS pandemic.10
Again,
it should be noted that the African “volunteers”
inhabited a geographic area consistent with the highest rates
of HIV-1 seroprevalence. Among the nations where rates are
highest, HB studies were conducted in: Senegal, Cote d’Ivoire,
Uganda, Kenya, Swaziland, and the northeastern part of South
Africa. According to circumstantial evidence, eastern Zaire
bordering the West Nile region of northwest Uganda also hosted
such trials.2,25-27
Historic
Precedence for the HB Vaccine Hypothesis
There
is historic precedence for this precise HB thesis. According
to Beale, the risk of HB viruses contaminating human blood
serum and subsequent vaccinations was determined as early
as 1942. Then, more than 62 deaths and 28,500 cases resulted
from serum HB contaminated yellow fever vaccines.31
According
to Hilleman, early yellow fever vaccines also delivered leukemic
retroviruses to human populations due to caged animal and
laboratory contaminations and concomitant vaccine transmissions.13
Dr.
Hilleman additionally reinforced this “punctuated origin”
thesis by describing the risks he encountered by importing
contaminated African sub-human primates for vaccine research
and development at the Merck pharmaceutical company. Between
the late 1950s through the 1970s, Dr. Hilleman told Harvard
medical historian Edward Shorter in 1987, “I brought
African greens in. I didn’t know we were importing AIDS
virus at the time.”13
Given
these statements of fact, it is reasonable to suggest, as
stated above, the earliest HB vaccine pilot studies may have
activated an endogenous or exogenous HIV-related retroviral
gene in one or more of the primates,24
fulfilling the “starburst phylogeny” antecedents
advanced by Myers et al.10
During
the Royal Society’s symposium on the origin of AIDS,
Hooper’s 1950s OPV/AIDS hypothesis was largely rebuked
because he failed to establish the use of chimpanzees by the
Wistar Institute in the production of the suspected OPV.18
Moreover, this vaccine was not given selectively to New York’s
gay male population. Curiously, Merck’s early 1970s
hepatitis B vaccine trials that did involve gay men in NYC,
and Blacks in central Africa, partially prepared in Litton
Bionetics (LB) exported/Merck imported African chimpanzees,
ironically went without mention.
“Burden
of Proof” and the Origin of AIDS
The
most vocal opponent of the OPV and HB vaccine theories of
HIV/AIDS origination is Dr. John Moore, affiliated with Rockefeller
University’s Aaron Diamond Research Center in New York.
As
reported in Medical Hypothesis, following a presentation advancing
the HB vaccine theory of HIV/AIDS at the XI International
Conference on AIDS, in 1996, Dr. Moore flippantly rebuked
this thesis in the Canadian press. A few years later, he did
the same regarding the Edward Hooper’s book, The River,
which he alleged was historically inaccurate, potentially
damaging to the public’s trust in western medicine,
and harmful to his colleagues “efforts to make AIDS
vaccines for use in Africa.”2
When
this author personally contacted Dr . Moore in an effort to
begin scientific discourse following his Canadian press interview,
Moore refused any formal discussion. Responding later to prodding,
he wrote me from the Aaron Diamond AIDS Research Center saying,
“I explicity denied you an interview when you requested
one. . . . I said to you that I had ‘no interest’
in your . . . grotesque theories . . . For the record, I know
what your views are, and I reject them. Indeed, I dismiss
them as uninteresting, incorrect and downright stupid.”
In the Vancouver Sun, Moore was further quoted as saying,
“HIV is transmitted from monkeys to humans. I don’t
think there’s any doubt about that. It’s hard
scientific reality.” In fact, according to scientific
consensus, the defining zoonosis for the origin of HIV occurred
between chimpanzees and humans, not monkeys.2
It
should be noted that Dr. Moore’s institutional benefactors
include the Rockefeller family which, along with the Rockefeller
Foundation and its institutional affiliate—the Sloan-Kettering
Memorial Cancer Center in New York—has heavily invested
in
viral
cancer research, vaccine developments, propaganda programs,
population control efforts, and the Merck pharmaceutical company
in particular. Thus, Moore’s bias is strongly suggested.2,13,14
Worse
yet, history shows that soon after Dr. Gallo’s alleged
“discovery” of the AIDS virus in 1984, Dr. Moore
co-directed the only official effort to examine Merck’s
HB vaccine for “fear of possible AIDS transmission.”23 His
principle co-investigator was Dr. B.J. Poiesz at the State
University of New York. Dr. Poiesz, their paper noted, had
worked closely with Dr. Gallo in isolating the “type-C”
cancer virus associated with lymphomas during the mid to late-1970s. Their
group of researchers included “anonymous CDC authors”
who, for unspecified reasons, omitted the centrally important
New York City and African HB vaccine recipients from their
analysis. Adding insult to this injury, the team’s conclusions
were entirely inconsistent with earlier epidemiological
determinations and serological measures.13
Reinforcing
the observance of such political bias and tainted science
in this field of inquiry is the conclusion reached by several
featured speakers at the Royal Society’s meeting in
London. They addressed the “burden of proof” required
of iatrogenic versus natural AIDS origin theorists. 10,
19, 20 These
experts protested the unfair unscientific advantage that has
been historically given to outspoken natural evolution theorists,
such as Dr. Moore, who have been curiously exempt from having
to substantiate their obviously flawed claims and hypotheses.
Ironically, despite this, their unproven misguided theories
remain widely accepted as supposed fact.10,
19,20
The
only remedy such deception is updated knowledge regarding
the advanced genetic analyses that have seriously undermined
arguments for isolated viral leaps that cannot adequately
explain the source of AIDS and the “sunburst phylogeny”
of HIV’s earliest African strains.10
In the wake of the Royal Society’s symposium, theories
that now appear tenuous, if not ludicrous, include isolated
parenteral (i.e., skin piercing) injuries (e.g., the “cut
hunter theory”), nutritional exposures, population movements,
and climatic variations that are alleged to have led to isolated
zoonotic events followed years later, evolutionarily, by the
spreading plague. Alternatively, many participants at the
conference concluded that the transfer of SIV to human beings
was probably connected with unprecedented medical activity
in Africa in the 20th century.”21
Bionetics
Evidence to be Reconciled
What
continues inadequately reported in the scientific literature,
perhaps because researchers remain unaware, or because most
investigators would certainly feel threatened by such disconcerting
revelations, was that the precise scenario advanced by Myers
et al.,10 to best account for the
sunburst phylogeny and “punctuated origin” event
was repeatedly engineered and studied during the Litton Bionetics
(LB) administered SVCP, at precisely the time (1969-1974)
required to produce the “Big Bang,” as Myers originally
called it. At this same time, LB’s study of HB viral
co-infections with viruses currently linked to HIV-related
immune suppression and AIDS symptomatology was ongoing, as
you will read below. This information comes directly from
their contract titled, “Investigations of Viral Carcinogenesis
in Primates” (NIH Grant Number 71-2025 beginning February
12, 1962). This team, officiated by NCI “Project
Officer” Dr. Robert Gallo, the subsequent discoverer
of HTLV-1,2 (leukemia viruses) and
HIV-1 (the AIDS virus) almost 15 years later, stated:
“During
the past year [1970] macaques were inoculated at birth or
in utero with the Mason-Pfizer monkey mammary virus, Epstein-Barr
virus (EBV), Herpesvirus saimiri, and Marek’s disease
virus. EB virus was given with immunostimulation and immunosuppression
(ALS, prednisone, imuran). Australian antigen [HB virus] was
given to newborn African green monkeys.”
Might
this quoted knowledge have impacted Dr. Gallo’s earliest
declaration that the origin of HIV-1 came from “African
greens” (i.e., SIVagm), and/or Dr. Hilleman’s
confession that he brought the AIDS virus into North America
in African greens?
Furthermore,
it is well known that HIV-2 sources from macaque monkeys from
this same time period.8 Might this
specific multiply-infected simian colony be the source of
the original SIV to HIV zoonosis? There is much evidence to
suggest this, and it is certainly worthy of an official inquiry.
It
is also curious that EBV was of major interest to the LB team
of researchers.
It
is also well known that EBV is a potent co-carcinogen with
HIV-1 and deadly co-factor in the development of AIDS.
This
1971 report by Landon, Ting and Gallo et al., referenced the
use of “colony-born” primates observed for seroconversion
to “EB positive” immune suppressive status predisposing
the animals for retroviral infections and cancers. To summarize
this work, conducted almost a decade before Dr. Gallo “discovered”
the first leukemia retrovirus (HTLV-I), and later HIV-1, his
Bionetics coworkers disclosed that their:
“reeding
and holding colonies were surveyed for antibody to EBV. All
breeders were positive and their offspring contain maternal
antibody for several months. . . . [Moreover,] An RNA-dependent
DNA polymerase, [the primary AIDS-linked enzyme] similar to
that associated with RNA tumor viruses, was detected in human
leukemic cells but not in normal cells stimulated by phytohemagglutinin.
The enzyme was isolated, purified and concentrated 200-fold,
making possible its further characterization and study in
relation to the leukemic process in man.”33
This
document, and statement alone, considering its date, should
be adequate impetus for an independent investigation into
the SVCP with regard to the origin of AIDS.
Reflecting
on the specific scenario advanced by Myers and co-workers
regarding the phylogenetic, recombinant, and immunosuppressive
correlates and antecedents of the “starburst”
that reflects at least ten simultaneous HIV/AIDS African outbreaks,
the Bionetics investigators stated the significance and “proposed
course” of their vaccine research involving chimpanzees. They
wrote:
“Significance
to Biomedical Research and to the [Special Virus Cancer] Program
of the [National Cancer] Institute: Inasmuch as tests for
the biological activity of candidate human [cancer] viruses
will not be tested in the human species, it is imperative
that another system be developed for these determinations
and, subsequently for the evaluation of vaccines or other
measures of control. The close phylogenetic relationship of
the lower primates [i.e., chimpanzees] to man justifies utilization
of these animals for these purposes. Further study of altered
transfer RNA and polymerase enzymes would determine their
significance in neoplastic change and provide a basis for
selection of therapeutic agents.
“Proposed
Course: Continuation with increased emphasis on monitoring
and intensive care of inoculated animals to determine if active
infection occurs, effects of infection, and degree of immunosuppression
when used. Further studies of human neoplasms at a molecular
level will continue.”33
Inasmuch
as humans were not being directly infected with “candidate
viruses” during this program according to the contract
summary, live viral vaccines derived from retroviruses similar
to the HIVs were being prepared and tested in primate populations
that apparently included humans as well as chimpanzees. This
at the precise time that the Australian antigen—the
HB highly infectious and easily transmissible cancer virus—and
related HB vaccines were being injected into both chimpanzees
and humans in New York and Sub-Saharan Africa by LB collaborators.33
At
the XI International Conference on AIDS in 1996, when questioned
regarding his involvement in these Bionetics studies, Dr.
Gallo angrily replied to this author, “Quite frankly,
I don’t know what the hell you’re talking about.”13
If the HB vaccine theory might be the focus of a reputable
independent inquiry, such as the one urged by Cribb,19
and now AI members, Dr. Gallo might be obliged to formally
discuss his contract with Bionetics wherein the “Australian
antigen was given to newborn African green monkeys”
in the context of testing “a swarm of [candidate viral
and retroviral] variants.” If he still contends this
HB vaccine/origin of AIDS theory has no merit, as he argued
forcefully at that time, then perhaps he would be willing
to publish an alternative account reflecting more recent scientific
revelations.
Huebner
et al, referred to in Bionetics’s SVCP contract (NIH-71-2025),
might also be persuaded to divulge valuable insights regarding
this HB vaccine/origin of AIDS thesis.34
At that time, 1969, Dr. Robert Huebner was also a leader in
this field on the esteemed National Academy of Sciences–National
Research Council (NAS–NRC), that is, at precisely the
time the Congressional Appropriations Committee heard testimony
concerning the technical expertise available through the NAS–NRC
for the U.S. Army’s development of AIDS-like viruses.
At that time these viruses were referred to by military personnel
in the Congressional Record as “synthetic biological
agents.” However, the scientific community referred
to them as “type-C” RNA tumor viruses. Huebner
was exquisitely aware of these developments and various retroviral
species that were routinely being generated using crude early
methods of recombination in SVCP labs. Again, these viruses
were descriptively and functionally identical to HIV-1.2,3,13,14 According
to the Bionetics contract summary report from 1972, Dr. Huebner’s
group isolated and tested a cat/human hybrid oncornavirus,
RD-114, from a human sarcoma by 1971. Sarcomas, associated
with leukemias and lymphomas in AIDS patients were, at that
time, unheard of in gay men. Later, in 1981, HB virus and
vaccine expert, Dr. Don Francis, relayed his opinion as to
the source of the first GRID (AIDS) cases in New York, “It’s
a combination of feline leukemia and hepatitis B,” he
told his mentor Max Essex at Harvard.35
The
following SVCP contract excerpt34 discusses the testing of
effective treatments for HIV/AIDS-like infections at that
early date:
“The
effects of 11 rifamycin derivaties on viral reverse transcriptase
and on DNA polymerases from human normal and leukemic blood
lymphocytes were evaluated. Compound 143-483, 3-formyl rifamycin
SV: octyl oxime showed the greatest potency and inhibited
all DNA polymerases from both viral and cellular origins.”
Might
this be a cure for HIV/AIDS? Unless further investigations
into this matter are conducted, we may never know.
Reflecting
on these revelations in-so-far-as the myriad viral recombinants
potentially contaminating LB’s labs and caged animals,
and the determinations of Myers et al,10
a most appropriate question is, “Why only ten forms
of HIV/AIDS broke out during the early1970s?” It would
seem likely that many of the SIVs originated from these investigations
as well as other pandemics such as herpes that exploded during
the mid to late 1970s along with immune suppressive disorders
associated with EBV infections and related cancers. Obviously,
it would be helpful to investigate the possibility of other
plagues that may have derived from vaccine contaminations
and transmissions during the SVCP.
Many
researchers, in fact, issued forewarnings about the grave
risks posed by recombinant cancer virology.13
Others cited similar risks from public health’s “sacred
cow” vaccinations.31 It is
sobering to reflect on this knowledge in the wake of the Royal
Society’s publications and official evaluations.19
Considering
The Genocidal Theory of AIDS
The
1998 report of Zhu et al.9 was well
timed to help promote co-author Edward Hooper’s book,
The River, which substantially reinforced a previously advanced
OPV theory of AIDS’s origin,12
and gave only superficial consideration to possible hepatitis
B vaccine contaminations as the zoonotic vector for transferring/transforming
SIVcpz into the human AIDS virus by 1976.4
Hooper referenced Emerging Viruses: AIDS & Ebola—Nature,
Accident or Intentional? among the texts that explore the
genocidal theory of AIDS which he credited for his background
on the hepatitis B theory.13 He
cautioned against blanket acceptance of the intentional theory
of HIV/AIDS, which is consistent with the proposed AI investigation
of the SVCP, but he did not rule out the possibility that
HIV was released intentionally.4
As
Weiss stated, theories involving the CIA in the origin of
AIDS have gained wide acceptance.6
Investigations by Horowitz et al.2,3,13
focused on the CIA and the 1969 appropriations hearings in
which the NAS–NRC was credited as the source of technical
expertise for the U.S. Army’s development of AIDS-like
viruses. At that time, biological weapons were of great interest
to Nelson Rockefeller’s protégé, and Nixon
administration National Seurity Advisor (NSA), Dr. Henry Kissinger.
According to his biographer, and two previous CIA directors—William
Colby and Richard Helms—Kissinger oversaw the CIA’s
top secret biological weapons program called MK:NAOMI. Soon
after becoming NSA, he ordered a review of such weapons capabilities.13-15
Furthermore,
in the early 1970s, in keeping with U.S. Government and global
industrialists’ initiatives reflecting Rockefeller-directed
Population Council urgings for Third World depopulation, Kissinger
requested and received National Special Security Memorandum
200 articulating the urgency of dramatically reducing African
populations.16 At that time Kissinger
and associates were leading advisors to the Merck pharmaceutical
company whose president, George W. Merck, was America’s
biological weapons industry director, as he had been since
World War II.17
According
to Hooper, the genocidal hypothesis of HIV/AIDS should be
“taken with a grain of salt.”4 It
is clear, however, that compelling evidence exits, albeit
circumstantial, that U.S. Government officials, including
Henry Kissinger, may have had something to do with the initial
HIV/AIDS outbreak. At the precise time corresponding to the
earliest transmissions of HIV/AIDS, Kissinger directed a national
security cryptocracy that included corporate affiliates at
the biological weapons contractor /vaccine maker Merck, as
well as the traditional weapons contractor Litton Industries.
Litton’s president, Roy Ash, also served in the Nixon
administration overseeing American industry. Litton’s
medical subsidiary, Bionetics, as detailed above, largely
directed the NCI’s SVCP, administered America’s
premier biological weapons testing center at Fort Detrick,
Maryland, and supplied the chimpanzees, monkeys, monkey viruses,
primate cell lines, and other resources for cancer research,
biological weapons development, and
vaccine manufacture.
Thus,
Kissinger certainly maintained the means, through his official
channels at Merck, Litton Bionetics, and the CIA, as well
as the motive, to deploy AIDS-like viruses by 1974 in Merck’s
HB vaccine. What is unconscionable to most people, Kissinger,
a staunch advocate of African depopulation, would have considered
it convenient that the emergence of HIV/AIDS in sub-Saharan
Africa coincided synchronously with the massive depopulation
policy institutionalized with primary funding from the Rockefeller
Foundation and the Merck Fund.2,3,13,14
Most
recently, Kissinger’s direction of foreign genocidal
operations has been heralded by even mainstream periodicals.36
In light of these revelations, it is stunning that Kissinger
wrote his own genocide indemnification policy on behalf of
the United States Government in Foreign Affairs published
by the Council on Foreign Relations in 2001.37
The
Challenge Before Us
“There
is a crisis of public faith in science and scientists,”
stated Dr. Julian Cribb, referring to the contentious manner
in which origin of HIV/AIDS research and debate has been conducted
thus far. “What I have described is . . . a systematic
endeavour to suppress public discussion and scientific inquiry
into this important [vaccine] hypothesis and to discredit
its proponents over more than 12 years.”
He
summarized before the esteemed Royal Society gathering. “Unless
scientists are prepared to go into this issue objectively
and transparently, it will damage the standing of science
in the eyes of the community.” 19
Determining
the origin of HIV/AIDS is vital for the following reasons
according to Cribb: 1) to prevent similar calamities in the
future; 2) to discover remedial
methods and materials that might evolve from such knowledge;
3) to improve safety standards in
viral laboratories and vaccine production facilities based
on the knowledge of the pandemic’s origin; and 4)
to restore faith and trust in this area of science and medicine.
19
Furthermore,
Cribb argued, “If AIDS is iatrogenic, through an honest
mistake, science may be forgiven. But if it seeks to bury
the idea, first, it will fail and second, it will destroy
public trust.” To the extent that the HB vaccine theory
of AIDS is officially neglected, as Hamilton foretold: “This
hypothesis is certainly not going to go away.”19
But
if the HB vaccine theory on the origin of AIDS, as current
science overwhelmingly supports and the “process of
elimination” has virtually proven, is ultimately accepted,
then Cribb’s forgivable “honest mistake”
conjecture might need to be reexamined against more unnerving
possibilities.
At
the time of this writing, the U.S. Homeland Security Act passed
the Senate virtually unanimously. Mysteriously incorporated
in its text was a vaccine injury indemnity clause that freed
drug companies from liabilities associated with specific vaccine
ingredients, such as HIV precursors in the HB vaccines. With
this gross violation of U.S. constitutional, civil, and human
rights, hundreds of thousands of Americans have been forced
to care, without compensation, for vaccine injured family
members. If the U.S. Government is able to get away with this
most blatant breach of public faith, what is it capable of
doing covertly? Clearly, this current vaccine policy
is a form of institutionalized genocide—defined as “the
mass enslaving (pharmaceutically and otherwise) and killing
of people for economics, politics, and/or ideology?”
So
long as the above scientific facts and AIDS issues remain
unaddressed by medicine’s mainstream, the implications
are that AIDS science and vaccination policies, and likely
all of science, has evolved in a vacuum devoid of ethics to
serve political, economic, and/or ideological motives. Thus,
by strict definition, genocide and iatrogenesis have much.
So much so that regardless of whether HIV/AIDS originated
by accident or intentionally, with this data, there is sufficient
justification to coin a new most appropriate term—“iatrogenocide.”
Further
research to test this hypothesis should include: retrospective
epidemiological studies of homosexual populations in New York
reported to have received the earliest HB vaccines; serological
studies of any stored blood and/or serum from these early
HB vaccine study subjects; likewise for the chimpanzees used
in the preliminary trials and/or vaccine manufacture; and
genetic analyses of viral components in samples of the vaccine
lots used during these earliest HB vaccine trials (if still
available).
About
the Author
Leonard
G. Horowitz, D.M.D., M.A., M.P.H., is an internationally known
authority in the overlapping fields of public health, behavioral
science, emerging diseases, and bioterrorism. He received
his doctorate in medical dentistry from Tufts University School
of Dental Medicine in 1977, was awarded a post-doctoral fellowship
in behavioral science at the University of Rochester, earned
a Master of Public Health degree from Harvard University,
and another Master of Arts degree in health education from
Beacon College, all before joining the research faculty at
Harvard. Dr. Horowitz is best known for his national bestselling
book, Emerging Viruses: AIDS & Ebola—Nature,
Accident or Intentional? (Tetrahedron Press, 1998; 1-888-508-4787)
which
recently resulted in the United Stated General Accounting
Office investigating the man-made origin of AIDS theory. (See:
http://www.healingcelebrations.com/gao.htm) Dr. Horowitz’s
brilliant work in the field of vaccination risk awareness
has prompted at least three Third World nations to change
their vaccination policies. His recent stunning testimony
before the United States Congress’ Government Reform
Committee, literally brought the hearing to a halt. (See:
http://www.healingcelebrations.com)
Dr. Horowitz questioned government health officials regarding
a Centers for Disease Control and Prevention (CDC) secreted
report showing a definitive link between the mercury ingredient
(i.e., thimerosal), common to most vaccinations, and the skyrocketing
rates of autism and behavioral disorders affecting our children
and the future our nation.
Incredibly,
Dr. Horowitz alerted the FBI, in writing and in person, one
week before the first anthrax mailing was announced in the
press, that a “major anthrax fright” was in the
process of unfolding that demanded the FBI’s urgent
attention. Needless to say they did not heed Dr. Horowitz’s
prophetic warning.
Moreover,
three months before the September 11 attacks on the World
Trade Center and Pentagon, Dr. Horowitz released his thirteenth
book, prophetically titled Death in the Air: Globalism, Terrorism
and Toxic Warfare. The book focuses on the West Nile Virus
as an act of bioterroism, and considers what and who is really
behind this and other recent outbreaks. Dr. Horowitz argues
that his disclosures expose the roots of global terrorism,
along with the individuals and organizations at the heart
of what he calls “the petrochemical–pharmaceutical
cartel.” He believes this “multi-national corporate
beast” is in the process of committing global genocide,
profiting from engineered frights, and at the same time, most
efficiently culling targeted populations considered excessive.
Very
recently, you may have heard that Senator Patrick Leahy (D-VT),
Chairman of the Senate Judiciary Committee, called for an
investigation into the links between the recent West Nile
Virus outbreaks and bioterrrorism. Dr. Horowitz is the principle
pioneer and investigator of this theory.
Dr.
Horowitz’s contact information, books, audiotapes, and
video programs are available through www.tetrahedron.org,
or by calling 1-888-508-4787.
References
(1)
Heinrich J. Origin of AIDS Virus. Washington, DC: U.S. General
Accounting Office, GAO-02-809R; available from http://
www.gao.gov/main.html. See also:Tetrahedron Publishing
Group press release, “U.S. GAO Commits Scientific
Fraud In AIDS Inquiry: Congressional Investigators Conceal
and Lie Says Expert,” available from healingcelebrations.com.
(2)
Horowitz LG. Polio, hepatitis B and AIDS: an integrative
theory on a possible vaccine induced pandemic. Med Hypoth
2001;56(5):677-686.
(3)
Horowitz LG, Strecker R, Cantwell SR, Vid, D, and Grossman
G. The Mysterious Origin of HIV: Reviewing the Natural,
Iatrogenic and Genocidal Theories of AIDS. XI International
Conference on AIDS, July 10, 1996, Vancouver, BC. Canada.
See full text of abstract and presented paper Here
(4)
Hooper E. The River. Boston: Little, Brown and Company,
1999.
(5)
Hamilton, WD., quoted by Julian Cribb in “The origin
of acquired immune deficiency syndrome: can science afford
to ignore it?” Phil. Trans. R. Soc. Lond. B 2001;356:935-938.
(6)
Weiss, RA, Natural and iatrogenic factors in human immunodeficiency
virus transmission. Phil. Trans. R. Roc. Lond. B 2001;356,947-953.
(7)
Yusim K, Peeters M. Pybus OG and Korber B, et al. Using
human immunodeficiency virus type 1 sequences to infer historical
features of the acquired immune deficiency syndrome epidemic
and human immunodeficiency virus evolution. Phil. Trans.
R. Roc. Lond. B 2001;356,855-866.
(8)
Sharp PM, Bailes E, Chaudhuri RR and Hahn BH, et al. The
origins of acquired immune deficiency syndrome viruses:
where and when? Phil. Trans. R. Roc. Lond. B 2001;356,867-876.
(9)
Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM and Ho
DD. An African HIV-1 sequence from 1959 and implications
for the origin of the epidemic. Nature 1998;391(Feb. 5):594-597.
(10)
Burr T, Hyman JM and Myers G. The origin of acquired immune
deficiency syndrome: Darwinian or Lamarchkian? Phil. Trans.
R. Soc. Lond. B (2001) 356:877-887; For early research regarding
the “Big Bang” theory of HIV, see also: Myers
G, Macinnnes K and Myers L. “Phogenetic moments in
the AIDS epidemic.” Chapter 12 in S.S. Morse, ed.,
Emerging Viruses (Oxford, Eng.: Oxford University Press,
1993).
(11)
Marx PA, Alcabes PG and Drucker E.11 “Serial human
passage of simian immunodeficiency virus by unsterile injections
and the emergence of epidemic human immunodeficiency virus
in Africa” Phil. Trans. R. Soc. Lond. B (2001) 356:911-920.
(12)
Elswood B and Stricker R. Polio vaccine and the origin of
AIDS. Med Hypoth 1994;42,347-354.
(13)
Horowitz LG and Martin WJ. Emerging Viruses: AIDS &
Ebola—Nature, Accident or Intentional? Sandpoint,
ID: Tetrahedron Publishing Group, 1998. Note: the Hilleman
revelations concerning leukemia virus tainted yellow fever
vaccines discussed on page 485 derive from a sequestered
recorded interview conducted in 1986 by Edward
Shorter for a Merck funded documentary, “The Health
Century.”
(14)
Horowitz LG. Death in the Air: Globalism, Terrorism
and Toxic Warfare. Sandpoint, ID. Tetrahedron Publishing
Group, 2001.
(15)
Isaacson W. Kissinger. New York: Simon & Schuster, 1992,
p. 205.
(16)
National Security Agency. National Special Security Memorandum
200: Implications of Worldwide Population Growth for U.S.
Security and Overseas Interests. The White House: December
10, 1974 (Declassified July 3, 1989.).
(17)
Covert NM. Cutting Edge: A history of Fort Detrick, Maryland
1943-1993. Fort Detrick , Maryland: U.S. Army Garrison,
Public Affairs Office, 1993, pp. 17, 20, 39.
(18)
Plotkin SA. Untruths and consequences: the false hypothesis
linking CHAT type 1 polio vaccination to the origin of human
immunodeficiency virus. Philos Trans R Soc Lond B Biol.
Sci. 2001 Jun 29:356(1410):815-823.
(19)
Cribb J. The origin of acquired immune deficiency syndrome:
can science afford to ignore it? Phil. Trans. R. Soc. Lond.
B 2001;356:935-938.
(20)
Martin B. The burden of proof and the origin of acquired
immune deficiency syndrome. Phil. Trans. R. Soc. Lond. B
2001;356:939-938.
(21)
Bliss M. Origin of AIDS (letter). The Lancet 2001;357 (January
6):73-74.
(22)
Gao F, Bailes E, Shaw GM, Sharp PM and Hahn BH et al. Origin
of HIV-1 in the chimpanzee Pan troglodytes troglodytes.
Nature 1999 (Feb. 4);397:436-440. See also: Horowitz LG.
Response to Zhu et al. 1959 Origin of AIDS. Unpublished
letter to the editor of Nature. Available for review Here
; See also: Horowitz L. Analysis of Gao F and Bailes E study.
Unpublished report available for review Here
(23)
Poiesz B, Tomar R, Lehr B and Moore J. (along with anonymous
CDC authors). Hepatitis B vaccine: Evidence confirming lack
of AIDS transmission. MMWR 1984;33;49:685-687.
(24)
Marriott SJ, Lee TH, Slagle B and Butel JS. Activation of
the HTLV-1 long terminal repeat by the hepatitis B virus
X protein. Virology 1996, 224;1:206-213.
(25)
Higginson J and Muir CS. Epidemiologic program of the International
Agency for Research in Cancer (IARC) In: The National Cancer
Program and International Cancer Research, National Cancer
Institute Monograph 1974 (40:65).
(26)
Jamison E and Hobbs F. World Population Profile: 1994, With
a Special Chapter Focusing on HIV/AIDS (WP/94) by Peter
O. Way and Karen A. Stanecki). Washington, DC: U.S. Government
Printing Office by the U.S. Department of Commerce, Washington,
DC, 1994.
(27)
Goodfield J. Quest for the Killers. Basel; Stuttgart: Birkhauser,
1985, p. 94.
(28)
Kanki PJ, Barin S, Essex M. et al. New human T-lymphotropic
retrovirus (HTLV-IV) related to simian T-lymphotropicvirus
Type III (STLV-IIIagm). Science 1986;232:238-43.
(29)
Schultz TF. Origin of AIDS (letter). The Lancet 1992;339:867.
(30)
Krugman S. Viral hepatitis type B: Prospects for active
immunization. In: International Symposium on Viral Hepatitis,
Milan, Dec. 1974. Develop. biol. Standard. Vol. 30, Munich:
S. Karger Basel, 1975, pp. VI; 363-367; relevant general
discussion can be found on pp.375-379; See also: Krugman
S, Giles JP, Hammond J. Hepatitis virus: effect of health
on the infectivity and antigenicity of the MS-1 and MS-2
strains. J Infectious Disease. 1970;122:432-6; Krugman S,
Giles JP, Hammond J. Viral hepatitis, type B (MS-2 strain):
Studies on active immunization. JAMA 1971;217:41-5; Krugman
S, Giles JP. Viral hepatitis, type B (MS-2 strain); further
observations on natural history and prevention. New England
Journal of Medicine 1973;288:755-60; and Krugman S, Overby
LR, Mushahwar IK, Ling C-M, Forsner GG and Deinhardt F.
Viral hepatitis, type B: Studies on natural history and
prevention reexamined. New England Journal of Medicine 1979;200:101-6.
(31)
Beale J. Origin of AIDS (letter). The Lancet 2001;357 (January
6):73.
(32)
Purcell RH. Current understanding of hepatitis B virus infection
and its implications for immunoprophylaxis. In: Antiviral
Mechanisms: Perspectives in Virology IX. The Gustav Stern
Symposium. New York: Academic Press, 1975, pp. 49-76.
(33)
NCI staff. The Special Virus Cancer Program: Progress Report
#8 [and #9]. Office of the Associate Scientific Director
for Viral Oncology (OASDVO). J. B. Moloney, Ed., Washington,
D. C.: U. S. Government Printing Office, 1971 [and 1972].
Note: This is a very hard publication to find. Few library
data bases have it listed, including the NCI Library at
Fort Detrick. It is available through the Davis Library,
The University of North Carolina, Chapel Hill, Government
Documents Department Depository, Reference # HE 20.3152:V81.
The Litton “support services” contracts that
included primate supplies are found on pp. 187-88 and 326-327
of the reports. Litton’s list of mutant viruses, including
retroviruses, and other experimental infectious agents including
AuAg is found on pp. 279-280 and 284 of Project Report #8,
of 1971; for additional documentation on hepatitis and herpes
experimentation in Uganda before 1971 see: Higginson J and
Muir CS. Epidemiologic program of the International Agency
for Research on Cancer (IARC). In: The National Cancer Program
and International Cancer Research, National Cancer
Institute Monograph, 1974; 40:65.
(34)
Rabin H, Kinard R. Gruber J and Pearson G. Bionetics Research
Laboratories, Inc. (NIH 71-2025) Investigations of viral
carcinogenesis in primates. Here reference is made to “Drs.
McAllister, Gardiner, and Huebner” having “isolated”
the cat-human hybrid oncornavirus, RD-114, “from a
human sarcoma” as early as 1971. See reprinted contract
summary in Horowitz, Op cit. 1998, p. 429.
(35)
Shilts R. The Band Played On. New York: Penguin Books, 1987,
p. 107.
(36)
Hitchens C. The Case Against Henry Kissinger. Harper’s
Magazine, February and March, 2001.
(37)
Kissinger HA. The pitfalls of universal jurisdiction. Foreign
Affairs. July/August 2001. Preview available from through
http://www.foreignaffaris.org.
|
| |
|
|
Even the plonkers at WHO seem confused over N1H1, Norway are going to give all its population 2 shots this Autumn.At present only 23 people have H1N1 in Norway.
WHO chief identifies warning signs of severe flu | Reuters
New flu may not spread like regular flu | Reuters
Japan finds first case of H1N1 resistant to Tamiflu | Reuters
Flu vaccine may be shot in arm for drug industry | U.S. | Reuters
The Norway Post - Mass vaccination against flu
|
|
|
|
|
Report
|
|
|
|
|
Evening News 24 » You Say » Opinion » Global Pandemic
|
|
|
|